Curriculum Vitae

Download this CV as a PDF

Last Updated 4/08

Name:
 Harrison G. Pope, Jr.
Address:
 115 Mill Street, Belmont, MA 02478
Place of Birth:
 Lynn, Massachusetts

Education:
1969 A.B.
 Summa Cum Laude, Harvard College, Cambridge, Massachusetts
1972 M.P.H.
 Harvard School of Public Health, Boston, Massachusetts
1974 M.D.
 Harvard Medical School, Boston, Massachusetts

Postdoctoral Training:

Internship and Residencies:
1974-1977
 Resident in Psychiatry, McLean Hospital, Belmont, Massachusetts
Research Fellowships:
1976-1977
 Dupont-Warren Fellowship, Harvard Medical School
1977-1979
 Fellowship, Charles A. King Trust, Boston, Massachusetts
1977-1981
 Fellowship, Scottish Rite Schizophrenia Program, Northern Masonic Jurisdiction, USA

Licensure and Certification:
1975
 Massachusetts License Registration
1980
 Diplomate, American Board of Psychiatry and Neurology

Academic Appointments:
1974-1977
 Clinical Fellow in Psychiatry, Harvard Medical School, Boston, Massachusetts
1977-1980
 Instructor in Psychiatry, Harvard Medical School, Boston, Massachusetts
1980-1982
 Clinical Instructor in Psychiatry, Harvard Medical School, Boston, Massachusetts
1982-1985
 Assistant Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts
1985-1999
 Associate Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts
1999-
 Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts

Hospital Appointments:
1976-1980
 Staff Psychiatrist, Hampstead Hospital, Hampstead, New Hampshire
1977-1984
 Assistant Psychiatrist, McLean Hospital, Belmont, Massachusetts
1984-1992
 Associate Psychiatrist, McLean Hospital, Belmont, Massachusetts
1984-
 Chief, Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts
1992-
 Psychiatrist, McLean Hospital, Belmont, Massachusetts

Other Professional Positions and Major Visiting Appointments:
1977
 Visiting Fellow, The Maudsley Hospital, London, U.K.
1977
 Visiting Fellow, L’Hopital Ste. Anne, Paris, France

Awards and Honors:
1969
 Phi Beta Kappa
1974
 The James Tolbert Shipley Prize, Harvard Medical School
1977
 Harvey Shein Award, McLean Hospital
1984
 Esquire Magazine Register of Outstanding Americans under 40
1988-
 Who’s Who in America
1990-
 Who’s Who in the World
1992-
 Best Doctors in America
1997-
 MERIT Award, National Institute on Drug Abuse

Major Committee Assignments:

National
1979
 Member, American Psychiatric Association Task Force on Nomenclature and Statistics, Advisory Committee on Schizophrenic, Paranoid, and Affective Disorders for DSM-III
1984
 Member, American Psychiatric Association Task Force on Nomenclature and Statistics, Advisory Committee on Eating Disorders for DSM-III-R
1995
 Member, Expert Consensus Panel to develop guidelines for bipolar disorder, Tri-University Consortium Hospital
1990-
 Member, Research Committee, McLean Hospital
1997-
 Member, Ethics Committee, McLean Hospital

Editorial Boards:
1984-1991
 Editorial Board, Psychiatrie et Psychobiologie, Paris, France
1984-
 Editorial Board, International Journal of Eating Disorders, Los Angeles, California
1991-
 Editorial Board, European Psychiatry, Paris, France
1993-
 Editorial Board, The Journal of Clinical Psychiatry, Tucson, Arizona
1997-1999
 Editorial Board, Journal of Bipolar Disorder, London, UK
2000-
 Editorial Board, Scientific Review of Mental Health Practice, Atlanta, Georgia
2003-
 Editorial Board, Body Image, Norfolk, VA

Advisory Boards:
1991-
 Advisory Board, Center for Science Technology & Media
1992-
 Scientific Advisory Board, False Memory Syndrome Foundation
1997-
 Charter Member, Council for Scientific Medicine, The Scientific Review of Alternative Medicine
1998-
 Professional Advisory Council, Neuroleptic Malignant Syndrome Information Service
1999-
 Technical Advisory Group to the CASA National Commission on Sports and Substance Abuse
  1. Report of Research

    1. Major Research Interests:

      • Diagnosis and treatment of psychotic and affective disorders
      • Etiology and treatment of eating disorders
      • Psychopharmacology
      • Drug Abuse
      • The “repressed” and “recovered” memory controversy

    2. Narrative Description of Research

      I have performed studies in many different areas of biological psychiatry over the course of the years. Starting in the late 1970s, my work on the diagnosis and classification of psychotic and affective disorders helped to stimulate revised diagnostic criteria for these disorders in DSM-III and subsequent diagnostic manuals. In the early 1980s, I conducted studies demonstrating the relationship of the eating disorders to major mood disorders, and was the first to publish a placebo-controlled, double blind study showing antidepressants to be effective in the treatment of bulimia nervosa. Throughout this same period, I conducted numerous studies in various aspects of psychopharmacology. Notable among these were the first published case series describing the “serotonin syndrome,” a major series of studies investigating the neuroleptic malignant syndrome, several additional open-label and placebo-controlled, double-blind studies of antidepressants in bulimia nervosa, and studies of anticonvulsants in the treatment of major mood disorders. Among the latter was the first large placebo-controlled study to demonstrate that valproate was effective for the manic phase of bipolar disorder.

      Starting in the 1990s, I focused increasingly on studies on substance abuse, including cannabis, hallucinogens, “ecstasy,” and anabolic steroids. I have published extensively on the neuropsychological effects of long-term cannabis use and related topics; neuropsychological performance among long-term hallucinogen users; and a pilot study of the neuropsychological effects of “ecstasy” use. Currently I am in the midst of a five-year study looking at the long-term or psychological effects of ecstasy in a much larger sample of users. In the area of anabolic steroids, I have published numerous papers over the last 20 years covering various aspects of anabolic steroid abuse, with particular attention to the psychiatric effects of steroids; among other studies, I have conducted the largest placebo-controlled study looking at the psychiatric effects of supraphysiologic doses of steroids, and I have performed several field studies looking at attributes of illicit steroid users and risk factors for steroid use.

      Also starting in the 1990s, I became interested in the important theoretical issue of “repressed memory,” (dissociative amnesia) and have published a series of papers and a book assessing the validity of the concept of “repressed memory,” and examining the related topics of childhood sexual abuse and other traumas.

      Finally, in collaboration with Dr. James Hudson, I have pursued a series of studies on the concept of “affective spectrum disorder” – the hypothesis that there is a large group of psychiatric and medical disorders that may share a common and possibly heritable physiologic abnormality. Following an initial presentation of this hypothesis (reference number 100 below), we have published a series of additional papers, including reports of recent large family studies, exploring this issue.

      My research activities also include teaching work with medical students, psychiatric residents, and junior investigators over the years, assisting them in conducting studies in numerous areas of psychiatry.

    3. Research Funding Information:

      Past:
      1979-1981
      		 NIDA - Co-Investigator
      Assessing the subjective effects of drugs in casual users
      1981-1989
      		 NIMH - Co-investigator
      Collaborative biological studies of schizophrenia
      1982-1983
      		 NIMH/Small grant - Principal Investigator
      Familial hyperkalemic periodic paralysis and manic-depressive illness: a linkage study
      1986
      		 Hoechst-Roussel Pharmaceuticals - Co-Investigator
      Nomifensine in the treatment of bulimia nervosa
      1985-1986
      		 Burroughs Wellcome Co. - Co-Investigator
      Bupropion vs. placebo in the treatment of bulimia nervosa
      1986-1987
      		 NIMH/R01 - Co-Investigator
      (Site Director) Test-Retest Reliability of the Structured Clinical Interview for DSM-III-R
      1986-1987
      		 Eli Lilly & Co. - Co-Investigator
      Fluoxetine vs. placebo in the treatment of bulimia nervosa
      1986-1987
      		 Mead Johnson Pharmaceuticals - Principal Investigator
      Trazodone vs. placebo in the treatment of bulimia nervosa
      1987-1989
      		 Abbott Laboratories - Principal Investigator
      Valproate vs. placebo in the treatment of acute mania
      1988-1989
      		 Eli Lilly & Co. - Co-Investigator
      Fluoxetine vs. placebo in the long-term treatment of bulimia nervosa
      1990-1991
      		 Eli Lilly & Co. - Co-Investigator
      Fluoxetine vs. placebo in the treatment of kleptomania
      1991-1992
      		 Glaxo Pharmaceuticals - Co-Investigator
      Ondansetron vs. diazepam vs. placebo in the treatment of generalized anxiety disorder
      1991-1992
      		 Eli Lilly & Co. - Co-Investigator
      Zatosetron vs. lorazepam vs. placebo in the treatment of generalized anxiety disorder
      1991-1992
      		 Abbott Laboratories - Co-Investigator
      Long-term follow-up of manic patients treated with valproate
      1990-1993
      		 NIDA/RO1-06543 - Principal Investigator
      Psychiatric effects of anabolic steroids
      1990-1994
      		 Harvard Medical School/Milton Fund - Co-Investigator
      Genetic epidemiology of affective spectrum disorder
      1991-1994
      		 NIDA/RO1-06522 - Principal Investigator
      Neuropsychological effects of marijuana in college students
      1992-1993
      		 Ciba-Geigy Co. - Co-Investigator
      Brofaromine vs. placebo in the treatment of social phobia
      1992-1994
      		 Pfizer, Inc. - Co-Investigator
      CP-93,393 vs. placebo in the treatment of generalized anxiety disorder
      1992-1994
      		 Pfizer, Inc. - Co-Investigator
      CP-93,393 vs. placebo in the treatment of major depression
      1993-1994
      		 The Upjohn Co. - Co-Investigator
      Fluvoxamine vs. placebo in the treatment of binge eating disorder
      1993-1994
      		 Ciba-Geigy Co. - Co-Investigator
      Placebo-controlled, dose ranging trial of oxcarbazepine in hospitalized inpatients with acute mania.
      1993-1995
      		 Abbott Laboratories - Principal Investigator
      Safety and efficacy of Depakote in the prevention of mania in patients with bipolar disorder.
      1994-1996
      		 Glaxo, Inc. - Co-Investigator
      Ondansetron vs. placebo in the treatment of panic disorder
      1994-1996
      		 The Upjohn Co. - Co-Investigator
      Pramipexole vs. placebo in the treatment of severe depression
      1995-1996
      		 GlaxoWellcome. - Co-Investigator
      Family study of panic disorder
      1994-1996
      		 Pfizer, Inc. - Co-Investigator
      CP 93,393-1 in patients with major depressive disorder
      1993-1997
      		 NIDA/R01-DA06543 - Principal Investigator
      Psychiatric Effects of Testosterone in Normal Men
      1996-1997
      		 Pfizer, Inc. Co-Investigator
      CP 93,393-1 vs. placebo in the treatment of generalized anxiety disorder
      1996-1997
      		 Pfizer, Inc. - Co-Investigator
      CP 93,393-1 vs. fluoxetine vs. placebo in the treatment of major depressive disorder
      1996-1997
      		 Eli Lilly & Company - Co-Investigator
      Fluoxetine vs. placebo in bulimia relapse prevention
      1996-1998
      		 NIDA/R01- DA10055 - Principal Investigator
      A Controlled Study of Anabolic Steroid Use in Women
      1997-1998
      		 Glaxo Wellcome, Inc. - Principal Investigator
      Evaluation of Lamotrigine in the long-term prevention of mood episodes in patients with rapid cycling bipolar disorder
      1996-2000
      		 NIDA/R01- DA10346 - Principal Investigator
      Cognitive Consequences of Long-Term Marijuana Use
      1998-2000
      		 CEASE, Inc. - Principal Investigator
      Development of a website to educate people about abuse of anabolic androgenic steroids
      1999-2001
      		 Webster Foundation - Principal Investigator
      Affective Spectrum Disorder
      1999-2002
      		 CEASE, Inc. - Principal Investigator
      Substance Use in Male Weightlifters
      2001-2002
      		 Unimed Pharmaceutical Co., Inc. - Principal Investigator
      Testosterone gel in men with major depressive disorder with low or borderline testosterone levels
      2000-2004
      		 NIDA/R37-DA10346 (MERIT AWARD)- Principal Investigator
      Cognitive consequences of long-term marijuana use
      2003-2005
      		 Ortho-McNeil Pharmaceutical - Co-Investigator
      Topiramate vs. placebo in the treatment of binge eating disorder
      Current
      2002-
      		 Ortho-McNeil Pharmaceutical - Co-Principal Investigator
      Family and genetic study of binge eating disorder
      2005-
      		 NIDA/R01 DA16744-01 A2 - Principal Investigator
      Risk factors for anabolic-androgenic steroid abuse
      2005-
      		 NIDA/R01 DA 017953 - Co-Investigator
      Neurocognitive consequences of long-term ecstasy use
      2005-
      		 Eli Lilly & Company - Principal Investigator
      A Comparison of LY686017, Paroxetine, and Placebo in the Treatment of Social Anxiety Disorder
      2006-
      		 Solvay Pharmaceuticals - Principal Investigator
      A Parallel-Group, Placebo-Controlled Trial of Androgel in Men with Major Depressive Disorder Who Display an Incomplete Response to Standard Antidepressant Treatment

    4. Principal Clinical and Hospital Service Responsibilities:

      1977-1979
      		 Psychiatrist-in-Charge, Clinical Evaluation Unit for Study of Psychotic Disorders, Laboratories for Psychiatric Research, McLean Hospital
      1990-
      		 Research Committee, McLean Hospital

  2. Report of Teaching:

    Local Contributions
    McLean Hospital
    1980-
    		 Psychopathology
    Lecturer on psychiatric disorders and eating disorders
    10-12 residents in psychiatry
    1-3 hours/year
    1982-
    		 Psychopharmacology
    Lecturer on pharmacologic treatment of psychotic disorders and eating disorders
    10-12 residents in psychiatry
    1-3 hours/year
    1983-
    		 Psychopharmacology
    Lecturer
    8-10 medical students
    1 hour/year
    1991
    		 Psychopharmacology Luncheon
    Speaker on psychotic disorders, eating disorders, and substance abuse
    20-30 staff psychiatrists, residents in psychiatry, and other hospital staff members
    2 hours/year
    1993-
    		 Psychopharmacology
    Supervise PGY-III residents on consultation service
    6-10 residents/year
    24 hours/year
    1993-
    		 Alcohol and drug abuse
    Lecturer on substance abuse
    20-50 staff psychiatrists, residents in psychiatry, and other hospital staff members
    2 hours/year
    Massachusetts Mental Health Center
    1986
    		 Psychopathology
    Lecturer on diagnosis of psychotic disorders
    10-12 residents in psychiatry
    2 hours
    Massachusetts General Hospital
    1994
    		 Psychopathology/case presentation and discussion
    Residents in psychiatry and nursing staff
    2 hours
    Harvard Medical School
    1995-
    		 Alcohol and drug abuse
    Lecturer on substance abuse
    10-15 medical students
    2 hours per year
    Harvard College
    2004-
    		 Anabolic steroid and ecstasy abuse
    Lecturer on substance abuse for Dr. Franz Schneider
    12-15 students
    2 hours per year
    Advising Responsibilities
    1982-
    		 Supervisor for residents in psychiatry on clinical and research activities
    1-2 residents/year
    1990-
    		 Preceptor for residents in psychiatry
    1-2 residents per year
    Regional, National, and International Contributions
    Invited Presentations
    1982-
    		 Lectures at approximately 20 regional and national courses on psychotic
    disorders, eating disorders, psychopharmacology, and substance abuse
    sponsored by academic institutions, hospitals, professional societies, and
    self-help organizations
    1984
    		 Invited Speaker, International Conference on Eating Disorders
    1986
    		 Plenary Speaker, International Conference on Eating Disorders
    1986
    		 Invited Speaker, Second International Conference on Eating Disorders,
    Sydney, Australia
    1986
    		 Chairperson, Symposium on Neuroleptic Malignant Syndrome
    American Psychiatric Association, Washington, DC
    1990
    		 Chairperson, Symposium on Anticonvulsants in Treatment of Psychiatric
    Disorders, American Psychiatric Association, Montreal, Canada
    1996
    		 Gast professur (Guest Professor)
    Department of Psychiatry, University Clinics of Innsbruck,
    Innsbruck, Austria
    Lectured on affective spectrum disorder, eating disorders,
    psychopharmacology, and childhood sexual abuse
    Teaching of Research Methods to Junior Investigators:
    1981-
    		 Principal teaching activity since 1977 has been the teaching of junior investigators in how to design, conduct, and publish research studies

    Since 1982, the following trainees have participated under supervision in projects resulting in their authorship on one or more published research studies in peer-reviewed scientific journals:

    1 Pre-college summer intern

    2 college undergraduates (thesis advisor for two honors theses, one at Harvard and one at Tufts)

    2 Masters candidates (One at Yale, One at Harvard)

    4 Ph.D candidates (Harvard University, USA; University of London, U.K.; and University of Innsbruck, Austria)

    4 Research Assistants/Pre-Med Students

    1 Medical Student

    3 Post-doctoral Fellows (1 United States, 2 Canada)

    21 Psychiatric Residents (20 at McLean Hospital, 1 in Sao Paulo, Brazil)

    During their training periods, these junior trainees have collectively become authors with Dr. Pope on 73 original articles in peer-reviewed journals and 20 reviews and book chapters

  3. Clinical Activities

    1. Short report of clinical activities
    1977- General private clinical practice of psychiatry, with emphasis on biological
    treatment of patients with psychotic disorders, major mood disorders, and eating
    disorders. Current practice is restricted to consultation time averaging
    less than four hours per week.

Bibliography:

Original Reports:

  1. Pope HG Jr. Tabernanthe iboga: an African narcotic plant of social importance. Economic Botany 1969;23:174-84.
  2. Walters PA, Jr., Goethals GW, Pope HG Jr. Drug use and life-style among 500 college undergraduates. Arch Gen Psychiatry 1972;26:92-6.
  3. Hirsch MS, Moellering RC, Jr, Pope HG, Jr, Poskanzer DC. Lymphocytic- choriomeningitis-virus infection traced to a pet hamster. New Eng J Med 1974;291:610- 12.
  4. Cole JO, Swett CP, Pope HG Jr. Agranulocytosis revisited. McLean Hosp J 1975;1:349.
  5. Pope HG Jr. From schizophrenia to affective illness: a question of diagnosis. McLean Hosp J 1976;2:108-19.
  6. Pope HG Jr, Lipinski J. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of “schizophrenic” symptoms in the light of current research. Arch Gen Psychiatry 1978;35:811-28.
  7. Cole JO, Pope HG Jr, LaBrie R, Ionescu-Pioggia M. Assessing the subjective effects of stimulants in casual users: methodology and preliminary results. Clin Pharmacol Therap 1978;24:243-52.
  8. Pope HG Jr. Drug Abuse and psychopathology. New Eng J Med 1979; 301:1341-43.
  9. Cohen BM, Lipinski JF, Pope HG Jr, Harris PQ. Neuroleptic blood levels of patients on thioridazine and clinical improvement. Psychopharmacology 1980;70:191-3.
  10. Cohen BM, Lipinski JF, Harris PQ, Sherman M, Pope HG Jr. Clinical use of the radioreceptor assay for neuroleptics. Psychiatry Res 1980;2:173-8.
  11. Pope HG Jr, Lipinski JF, Cohen BM, Axelrod D. Schizoaffective disorder: an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry 1980;137:921-7.
  12. Cohen BM, Miller AL, Lipinski JF, Pope HG Jr. Lecithin in mania: a preliminary report. Am J Psychiatry 1980;137:242-3.
  13. Cohen BM, Harris PQ, Pope HG Jr, Altesman RI, Lipinski JF. Radioreceptor assays in clinical psychiatric research. Psychopharmacology Bull 1980;16:82-4.
  14. Pope HG Jr, Ionescu-Pioggia M, Cole JO. Drug use and life-style among college undergraduates–nine years later. Arch Gen Psychiatry 1981;38:588-91.
  15. Hudson JI, Laffer PS, Pope HG Jr. Bulimia related to affective disorder by family history and response to the dexamethasone suppression test. Am J Psychiatry 1982;139:685-7.
  16. Pope HG Jr, Jonas JM, Cohen BM, Lipinski JF. Failure to find evidence of schizophrenia in the first-degree relatives of schizophrenics. Am J Psychiatry 1982;139:826-8.
  17. Lipinski JF, Pope HG Jr. Possible synergistic action between carbamazepine and lithium carbonate: a report of three cases. Am J Psychiatry 1982;139:948-9.
  18. Fogelson DL, Cohen BM, Pope HG Jr. A study of the validity of DSM-III schizophreniform disorder. Am J Psychiatry 1982;139:1281-5.
  19. Pope HG Jr, Jonas JM, Jones B. Factitious psychosis: phenomenology, family history, and long-term outcome of nine cases. Am J Psychiatry 1982;139:1480-3.
  20. Pope HG Jr, Hudson JI. Treatment of bulimia with antidepressants. Psychopharmacology 1982;78:176-9.
  21. Pope HG Jr, Jonas JM, Hudson JI, Cohen BM, Gunderson JG. Borderline personality disorder: a phenomenologic, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry 1983;40:23-30.
  22. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D. Family history study of anorexia nervosa and bulimia. Brit J Psychiatry 1983; 142:133-8.
  23. Hudson JI, Pope HG Jr, Jonas JM, Laffer PS, Hudson MS, Melby JC. Hypothalamic- pituitary-adrenal axis hyperactivity in bulimia. Psychiatry Res 1983;8:111-7.
  24. Pope HG Jr. Distinguishing bipolar disorder from schizophrenia in clinical practice: guidelines and case reports. Hosp Community Psychiatry 1983;34:322-8.
  25. Pope HG Jr, Ionescu-Pioggia M, Yurgelun-Todd D. Migration and manic depressive illness. Compr Psychiatry 1983;24;158-65.
  26. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled double-blind study. Am J Psychiatry 1983;140:554-8.
  27. Pope HG Jr, Hudson JI, Jonas JM. Antidepressant treatment of bulimia: preliminary experience and practical recommendations. J Clin Psychopharmacol 1983;3:274-81.
  28. Hudson JI, Pope HG Jr., Jonas JM, Yurgelun-Todd D. Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res. 1983;9:345-54.
  29. Zubenko G, Pope HG Jr: Management of a case of neuroleptic malignant syndrome with bromocriptine. Am J Psychiatry 1983;140:1619-20.
  30. Jonas JM, Hudson JI, Pope HG, Jr. Treatment of bulimia with MAO inhibitors. J Clin Psychopharmacol 1983;3:59-60.
  31. Pope HG Jr, Hudson JI, Yurgelun-Todd D. Anorexia nervosa and bulimia among 300 suburban women shoppers. Am J Psychiatry 1984;141:292-4.
  32. Pope HG Jr, Hudson JI, Yurgelun-Todd D, Hudson MS. Prevalence of anorexia nervosa and bulimia in three student populations. Int J Eat Disord 1984;3:45-51.
  33. Hudson JI, Pope HG Jr, Jonas JM. Psychosis in anorexia nervosa and bulimia. Br J Psychiatry 1984;145:420-3.
  34. Jonas JM, Pope HG Jr, Hudson JI, Satlin A. Unexplained vomiting in a 56-year-old woman: An unsuspected case of bulimia. Am J Psychiatry 1984;141:902-3.
  35. Pope HG Jr, Hudson JI, Poskanzer D, Yurgelun-Todd D. Familial hyperkalemic periodic paralysis and bipolar disorder: a linkage and treatment study. Biol Psychiatry 1984;19:1449-59.
  36. Jonas JM, Pope HG Jr. Psychosis in borderline personality disorder. Psychiatric Developments 1984;4:295-308.
  37. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D. Treatment of anorexia nervosa with antidepressants. J Clin Psychopharmacol 1985;5:17-23.
  38. Jonas JM, Pope HG Jr. The dissimulating disorders: a single diagnostic entity? Comp Psychiatry 1985;26:58-62.
  39. Hudson JI, Wentworth SM, Hudson MS, Pope HG Jr: Prevalence of anorexia nervosa and bulimia among young women with diabetes. J Clin Psychiatry 1985;46:88-93.
  40. Hudson JI, Hudson MS, Plinier LF, Goldenberg DL, Pope HG Jr. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985;142:441-6.
  41. Pope HG Jr, Jonas JM, Hudson JI, Kafka MP. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. Am J Psychiatry 1985;142:491-2.
  42. Weiss RW, Pope HG Jr, Mirin SM. Treatment of cocaine abuse and attention deficit disorder, residual type with magnesium pemoline. Drug Alcohol Dep 1985;15:69-72.
  43. Pope HG Jr, Jonas JM, Hudson JI, Cohen BM, Tohen M. Psychosis in borderline personality disorder: an empirical study. Am J Psychiatry 1985;142:1285-90.
  44. Pope HG Jr, Hudson JI, Mialet J-P: Bulimia in nineteenth century France: the observations of Pierre Janet. Psychological Med 1985;15:739-43.
  45. Herridge PL, Pope HG Jr. Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate. J Clin Psychopharmacol 1985;5:229-30.
  46. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D: Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 1985;5:320-7.
  47. Hudson JI, Pope HG Jr, Jonas JM. Antidepressant treatment of bulimia. Adv Behav Res Ther 1985;7:173-9.
  48. Pope HG Jr, Hudson JI, Nixon RA, Herridge PL. The epidemiology of ipecac abuse. New Engl J Med 1986;14:245-6.
  49. Pope HG Jr, Hudson JI, Jonas JM. Bulimia in men: a series of 15 cases. J Nerv Ment Dis 1986;74:117-9.
  50. Pope HG Jr, Herridge PL, Hudson JI, Fontaine R, and Yurgelun-Todd D. Treatment of bulimia with nomifensine. Am J Psychiatry 1986;143:371-3.
  51. Linden R, Jonas JM, Pope HG, Jr: Pathological gambling and major affective disorder: preliminary findings. J Clin Psychiatry 1986;47:201-3.
  52. Pope HG Jr, Hudson JI. Antidepressant drug therapy of bulimia: current status. J Clin Psychiatry 1986;47:339-45.
  53. Pope HG Jr, Cole JO, Choras T, Fulwiler CE. Apparent neuroleptic malignant syndrome with clozapine and lithium. J Nerv Ment Dis 1986; 174:493-5.
  54. Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986;143:1227-33.
  55. Pope HG Jr, Hudson JI, Zubenko GS, Jonas JM, Herridge PL. Schizoid personality disorder among psychiatric inpatients. McLean Hosp J 1986;9:1-9.
  56. Hudson JI, Pope HG Jr. Newer antidepressants in the treatment of bulimia. Psychopharmacol Bull 1987;23:52-7.
  57. McElroy SL, Keck PE Jr, Pope HG Jr. Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol 1987;7:16-24.
  58. Pope HG Jr, Katz DL: Bodybuilder’s psychosis. Lancet 1987;1:863.
  59. Hudson JI, Katz DL, Pope HG Jr, Hudson MS, Griffing GT, Melby JC. Urinary free cortisol and response to the dexamethasone suppression test in bulimia: a pilot study. Int J Eat Disord 1987;6:191-8.
  60. Pope HG Jr, Frankenburg FR, Hudson JI, Jonas JM, Yurgelun-Todd D. Is bulimia associated with borderline personality disorder? J Clin Psychiatry 1987;48:181-4.
  61. Hudson JI, Pope HG Jr, Jonas, JM, Stakes JW, Grochocinski VJ, Lipinski JF, Kupfer DJ. Sleep EEG in bulimia. Biol Psychiatry 1987;22:820-8.
  62. Keck PE Jr, Pope HG Jr, McElroy SL. Frequency of the neuroleptic malignant syndrome: experience in France and in the United States. Psychiatr Psychobiol 1987;2:59-63.
  63. Pope HG Jr, Hudson JI: Antidepressant medication in the treatment of bulimia nervosa. Psychopathology l987;Suppl. 1:123-9.
  64. Pope HG Jr, Champoux R, Hudson JI. Eating disorder and socioeconomic class: anorexia nervosa and bulimia in nine communities. J Nerv Ment Dis 1987;175:620-3.
  65. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D, Frankenburg FR. A controlled family history study of bulimia. Psychol Med 1987;l7:883-90.
  66. Hudson JI, Pope HG Jr, Yurgelun-Todd D, Jonas JM, Frankenburg FR. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry 1987;144:1283-7.
  67. Keck PE Jr, Pope HG Jr, McElroy SL. Neuroleptic malignant syndrome: a prospective study. Am J Psychiatry 1987;144:1344-6.
  68. Hudson JI, Hudson MS, Pope HG Jr, Griffing GT, Melby JC. Phenomenology and family history of affective disorder in Cushing’s disease. Am J Psychiatry 1987;144:951- 3.
  69. Hudson JI, Pope HG Jr, Wurtman J, Yurgelun-Todd D, Mark S, Rosenthal NE. A controlled study of obese women with bulimia. J Nerv Ment Dis l988;l76:144-52.
  70. Pope HG Jr, Hudson JI. Is bulimia a heterogeneous disorder? lessons from the history of medicine. Int J Eat Disord l988;7:155-66.
  71. Keck PE Jr, Pope HG Jr, Hudson JI, McElroy SL, Kulick A. Lycanthropy: alive and well in the twentieth century. Psychological Med 1988;18:113-20.
  72. Pope HG Jr, McElroy SL, Satlin A, Hudson JI, Keck PE Jr, Kalish R. Head injury, bipolar disorder, and response to sodium valproate. Compr Psychiatry l988;29:34-8.
  73. Pope HG Jr, Jr, Katz DL. Affective and psychotic syndromes associated with use of anabolic steroids. Am J Psychiatry l988;145:487-90.
  74. Hudson JI, Pope HG Jr, Yurgelun-Todd, D. Bulimia and major affective disorder: experience with 105 patients. Psychiatr Psychobiol l988; 3:37-47.
  75. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI. Treatment of psychiatric disorders with sodium valproate: a series of 73 cases. Psychiatr Psychobiol 1988;3:8l-5.
  76. Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, Cato A. Treatment of bulimia with bupropion: a controlled multi-center trial. J Clin Psychiatry 1988;49:262-6.
  77. Pope HG Jr, Cohen BM, Lipinski JF, Yurgelun-Todd D. DSM-III criteria for affective disorders and schizophrenia: a preliminary appraisal using family history findings. Psychiatr Psychobiol 1988;3:159-69.
  78. McElroy SM, Pope HG Jr, Keck PE Jr, Hudson JI. Sodium valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol 1988;8:27579.
  79. Pope HG Jr, McElroy SL, Nixon RA. Possible synergism between fluoxetine and lithium in refractory depression. Am J Psychiatry 1988;145:1292-4.
  80. Pope HG Jr, Katz DL, Champoux R: Anabolic steroid use among 1010 college men. Physician Sportsmed 1988;16:75-81.
  81. Pope HG Jr, Hudson JI, Yurgelun-Todd D. Depressive symptoms in bulimic, depressed, and non-psychiatric control subjects. J Affect Dis 1989;16:93-9.
  82. Pope HG Jr, Hudson JI. Are the eating disorders associated with borderline personality disorder? A critical review. Int J Eat Disord 1989;8:1-9.
  83. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI, Ferguson JM, Horne RL. Electrophysiologic abnormalities in bulimia and their implications for pharmacotherapy: a reassessment. Int J Eating Dis 1989;16:191-201.
  84. Hudson JI, Pope HG Jr, Keck PE Jr, McElroy SL. Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up. Clin Neuropharmacol 1989;12(suppl 1):S38-S46.
  85. Keck PE Jr, Pope HG Jr, Nierenberg AA. Autoinduction of hypertensive reactions by tranylcypromine? J Clin Psychopharmacol 1989;9:48-51.
  86. Keck PE Jr, Vukovic A, Pope HG Jr, Nierenberg AA, Gribble GW, White K. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment. J Clin Psychopharmacol 1989;9:203-6.
  87. Pope HG Jr, Keck PE Jr, McElroy SL, Hudson, JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989;9:254-9.
  88. Keck PE Jr, Sebastianelli J, Pope HG Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. J Clin Psychiatry 1989;50:352-5.
  89. Keck PE Jr, Pope HG Jr, Cohen BM, McElroy SL. Risk factors for neuroleptic malignant syndrome: a case-control study. Arch Gen Psychiatry 1989;46;914-8.
  90. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Long-term pharmacotherapy of bulimia nervosa. J Clin Psychopharmacol 1989;9:385-6.
  91. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Pharmacologic treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol 1989;9:358-60.
  92. Pope HG Jr, Lichter SR. The reporting of AIDS. JAMA 1989;262:1949-50.
  93. Hudson JI, Pope HG Jr. Fibromyalgia and psychopathology: is fibromyalgia a form of “affective spectrum disorder?” J Rheumatol 1989; 16(suppl 19):15-22.
  94. Aranow RB, Hudson JI, Pope HG Jr, Grady TO, Laage TA, Bell IR, Cole JO. Elevated antidepressant plasma levels following addition of fluoxetine. Am J Psychiatry 1989;146:911-3.
  95. Lipinski JR, Mallya G, Zimmerman P, Pope HG Jr. Fluoxetine-induced akathisia: clinical implications. J Clin Psychiatry 1989;50:339-42.
  96. Gutierrez-Esteinou R, Pope HG Jr. Does fluoxetine lengthen electrically-induced seizures? Convul Therap 1989;5:344-8.
  97. Kulick A, Pope HG Jr, Keck PE Jr. Lycanthropy and self-identification. J Nerv Ment Dis 1990;178:134-7.
  98. Pope HG Jr, Yurgelun-Todd D. Schizophrenic individuals with bipolar first degree relatives. J Clin Psychiatry 1990;51:97-101.
  99. Pope HG Jr, Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry 1990;51:28-31.
  100. Hudson JI, Pope HG Jr. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990;147:552-64.
  101. Zanarini MC, Frankenburg FR, Pope HG Jr, Hudson JI,Yurgelun-Todd D, Cicchetti CJ. Axis II comorbidity of normal-weight bulimia. Compr Psychiatry 1990;30:20-4.
  102. Pope HG Jr, Ionescu-Pioggia M, Aizley HG, Varma DK. Drug use and life-style among college undergraduates in 1989: a comparison with 1969 and 1978. Am J Psychiatry 1990;147:998-1001.
  103. Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HG Jr, McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry 1990;27:341-52.
  104. Keck PE Jr, Seeler DC, Pope HG Jr, McElroy SL: Porcine stress syndrome: an animal model for neuroleptic malignant syndrome? Biol Psychiatry 1990;28:58-62.
  105. Keck PE Jr, Pope HG Jr, Hudson JI, McElroy SL, Yurgelun-Todd D, Hundert EM. A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry 1990;31:275-83.
  106. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48:62-8.
  107. Hudson JI, Pope HG Jr, Goldenberg DL. Chronic fatigue syndrome. JAMA 1991;265:357.
  108. Pope HG Jr, Aizley HG, Keck PE Jr, McElroy SL. Neuroleptic malignant syndrome: long-term follow-up of 20 cases. J Clin Psychiatry 1991;52:208-12.
  109. McElroy SL, Hudson JI, Pope HG Jr, Keck PE Jr. Kleptomania: clinical characteristics and associated psychopathology. Psychol Med 1991;21:93-108.
  110. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Morris D. Correlates of antimanic response to valproate. Psychopharmacol Bull 1991;27:127-33.
  111. Pope HG Jr, Hudson JI. A supplemental interview for forms of “affective spectrum disorder.” Intl J Psychiatry in Medicine 1991;21:205-32.
  112. McElroy SL, Pope HG Jr, Hudson JI, Keck PE Jr, White KL. Kleptomania: a report of 20 cases. Am J Psychiatry 1991;148:652-7.
  113. Stoll AL, Pope HG Jr, McElroy SL. High dose fluoxetine: safety and efficacy in 27 cases. J Clin Psychopharmacol 1991;11:225-6.
  114. Keck PE Jr, Pope HG Jr, McElroy SL. Declining frequency of the neuroleptic malignant syndrome. Am J Psychiatry 1991;148:880-2.
  115. McElroy SL, Satlin A, Pope HG Jr, Keck PE Jr, Hudson JI. Treatment of compulsive shopping with antidepressants: A report of three cases. Ann Clin Psychiatry 1991;3:199- 204.
  116. McElroy SL, Dessain E, Pope HG Jr, Cole JO, Keck PE Jr, Frankenburg F, Aizley HG, O’Brien S. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-4.
  117. McElroy SL, Pope HG Jr, Woods BT, Hudson JI, Keck PE Jr, Aizley HG. Brain Electrical Activity Mapping (BEAM) in bulimia nervosa. Ann Clin Psychiatry 1991;3:281-6.
  118. Hudson JI, Weiss RD, Pope HG Jr, McElroy SL, Mirin SM. Eating disorders among hospitalized substance abusers. Am J Drug Alcohol Abuse 1992;18:75-85.
  119. Fluoxetine Bulimia Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139-147.
  120. McElroy SL, Hudson JI, Pope HG Jr, Keck PE Jr, Aizley HG. The DSM-III-R impulse control disorders not elsewhere classified: Clinical characteristics and relationship to other psychiatric disorders. Am J Psychiatry 1992;149:318-27.
  121. Pope HG Jr, Hudson JI. Is childhood sexual abuse a risk factor for bulimia nervosa? Am J Psychiatry 1992;149:455-63.
  122. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Medicine 1992;92:363-7.
  123. Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Kane J, Pope HG Jr, Rounsaville B, Wittchen HU. The Structured Clinical Interview for DSM-III-R (SCID), II: Multi-site test-retest reliability. Arch Gen Psychiatry 1992;49:630-6.
  124. Shedlack KJ, Pope HG, Jr. Anticonvulsant response in a case of anorexia nervosa and bipolar disorder associated with right-sided brain injury. Int J Eat Disord 1992;12:333-6.
  125. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992;149:1633-44.
  126. Hudson JI, Pope HG Jr, Keck PE Jr, Waternaux CM, Sullivan LE. Good sleep, bad sleep: a meta-analysis of polysomnographic measures in insomnia, depression, and narcolepsy. Biol Psychiatry 1992;32:958-75.
  127. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993;150:302-08.
  128. Pope HG Jr, Yurgelun-Todd D. A family interview study of schizophrenia, schizoaffective disorder, and affective disorder: updated findings. European Psychiatry 1993;8:1-5.
  129. Hudson JI, Pope HG Jr, Sullivan LE, Waternaux CM, Keck PE Jr, Broughton RJ. A meta-analysis of polysomnography in insomnia, depression, and narcolepsy. Sleep Res 1993;22:210.
  130. Hudson JI, Pope HG Jr, Daniels SR, Horwitz RI. Insomnia, L-tryptophan, and EMS: nature of the association remains unclear. Sleep Res 1993;22:35.
  131. Hudson JI, Lipinski JF, Keck PE Jr, Aizley HG, Vuckovic A, Zierk KC, Pope HG Jr. Sleep in schizophrenia. Sleep Res 1993;22:150.
  132. Hudson JI, Pope HG Jr, Daniels SR, Horwitz RI. Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia? JAMA 1993;269:3108.
  133. Hudson JI, Lipinski JF, Keck PE Jr., Aizley HG, Vuckovic A, Zierk KC, Pope HG Jr. Polysomnographic characteristics of schizophrenia in comparison with mania and depression. Biol Psychiatry 1993;34:191-3.
  134. McElroy SL, Hudson JI, Phillips KA, Keck PE Jr, Pope HG Jr. Clinical and theoretical implications of a possible link between obsessive-compulsive disorder and impulse control disorders. Depression 1993;1:121-32.
  135. McElroy SL, Phillips KA, Keck PE Jr, Hudson JI, Pope HG Jr. Body dysmorphic disorder: does it have a psychotic subtype? J Clin Psychiatry 1993;54:389-95.
  136. Banov MD, Kulick AR, Oepen G, Pope HG Jr. A new identity for misidentification syndromes. Compr Psychiatry 1993;34:414-7.
  137. Pope HG Jr, Katz DL, Hudson JI. Anorexia nervosa and “reverse anorexia” among 108 male bodybuilders. Compr Psychiatry 1993;34:406-9.
  138. Hudson JI, Keck PE Jr, Lipinksi JF, Aizley HG, Pope HG Jr. Polysomnographic characteristics of bipolar depression. Depression 1993;1:227-30.
  139. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408.
  140. Tohen MT, Castillo J, Pope HG Jr, Herbstein J. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorder. J Clin Psychopharmacol 1994;14:67-70.
  141. Gruber AJ Pope HG Jr. Cannabis psychotic disorder: does it exist? Am J Addictions 1994;3:72-83.
  142. Pope HG Jr, Mangweth B, Negrao AB, Hudson JI, Cordas TA. Childhood sexual abuse and bulimia nervosa: a comparison of American, Austrian, and Brazilian women. Am J Psychiatry 1994;151:732-7.
  143. Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroids: A controlled study of 160 athletes. Arch Gen Psychiatry 1994;51:375-82.
  144. Ghaemi SN, Pope HG Jr. Lack of insight in psychotic and affective disorders: a review of empirical studies. Harvard Review of Psychiatry 1994;2:22-33.
  145. Lipinski JF, Pope HG Jr. Do flashbacks represent obsessive-compulsive imagery? Compr Psychiatry 1994;35:245-7.
  146. Choi PYL, Pope HG Jr. Violence towards women and illicit androgenic-anabolic steroid use. Ann Clin Psychiatry 1994;6:21-5.
  147. McElroy SL, Keck PE Jr, Pope HG Jr, Smith J, Strakowski SM. Compulsive buying: A report of 20 cases. J Clin Psychiatry 1994;55:242-8.
  148. Phillips KA, McElroy SL, Keck PE Jr, Hudson JI, Pope HG Jr. A comparison of delusional and non-delusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994;30:179-86.
  149. Hudson JI, Pope HG Jr. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and pain. Balliere’s Clin Rheumatol 1994;8:839-56.
  150. Mangweth B, Hudson JI, Pope HG Jr. Familenhintergrund bulimischer Frauen: ein crosskultureller Vergleich oesterreichischer und amerikanischer Studentinnen. Zeitschrift fur Klinische Psychologie, Psychopathologie und Psychotherapie 1995;43:57-74.
  151. Pope HG Jr, Hudson JI. Can memories of childhood sexual abuse be repressed? Psychol Med 1995;25:121-6.
  152. Hudson JI, Pope HG Jr. Does childhood sexual abuse cause fibromyalgia? Arthritis Rheum 1995;38:161-3.
  153. Hudson JI, Pope HG, Daniels SR, Horwitz RI, Goldenberg DL. Fibromyalgia and eosinophilia-myalgia syndrome. J Musculoskeletal Pain 1995;3:63-75.
  154. Mangweth B, Pope HG, Hudson JI. Bulimia nervosa in two cultures: a comparison of Austrian and American college students. Int J Eat Disord 1995;17:403-12.
  155. Phillips KA, McElroy SL, Hudson JI, Pope HG Jr. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry 1995; 56 (Suppl 4):41-51.
  156. Pope HG Jr, Gruber AJ, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend 1995;38:25-34.
  157. Bond AJ, Choi PYL, Pope HG Jr. Assessment of attentional bias and mood in users and non-users of anabolic steroids. Drug Alcohol Depend 1995;37:241-5.
  158. Olivardia R, Pope HG Jr, Mangweth B, Hudson JI. Eating disorders in college men. Am J Psychiatry 1995;152:1279-85.
  159. Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH Jr.,The Fluoxetine Bulimia Nervosa Research Group. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166: 660-6.
  160. First MB, Spitzer RL, Gibbon M, Williams JBW, Davies M, Borus J, Howes MJ, Kane J, Pope HG Jr, Rounsaville B, Wittchen HU. The Structured Clinical Interview for DSM- III-R Personality Disorders (SCID-II) Part II: Multi-site test-retest reliability study. J Personality Disord 1995;9:92-104.
  161. Ghaemi SN, Stoll AL, Pope HG Jr, Hebben N. Lack of insight in bipolar disorder: the acute manic episode. J Nerv Ment Dis 1995;183:464-7.
  162. Kouri EM, Pope HG Jr, Katz DL, Oliva PS. Fat-free mass index in users and non-users of anabolic-androgenic steroids. Clin J Sport Med 1995;5:223-8.
  163. Ram A, Cao Q, Keck PE Jr, Pope HG Jr, Otani K, Addonizio G, McElroy SL, Kaneko S, Redlichova M, Gershon ES, Gejman PV. Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome. Am J Med Genet 1995;60:228- 30.
  164. Kouri E, Pope HG Jr, Yurgelun-Todd D, Gruber S. Attributes of heavy vs. occasional marijuana smokers in a college population. Biol Psychiatry 1995;38:475-81.
  165. Kouri EM, Lukas SE, Pope HG Jr, Oliva PS. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend 1995;40:73-9. Corrigendum to “Increased aggressive responding in male volunteers following the administation of gradually increasing doses of testosterone cypionate.” Drug Alcohol Depend 1998;50:255
  166. Bodkin JA, Klitzman R, Pope HG Jr,. Treatment orientation and associated characteristics of North American academic psychiatrists. J Nerv Ment Dis 1995;183:729-35.
  167. Pope HG Jr, Hudson JI. Does childhood sexual abuse cause adult psychiatric disorders? Essentials of methodology. J Psychiatry Law Fall 1995:363-81.
  168. Pope HG Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275:521-7.
  169. Pope HG Jr, Hudson JI. “Recovered memory” therapy for eating disorders: implications of the Ramona verdict. Int J Eat Disord 1996;19:139-45.
  170. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B, Pope HG Jr. Improved method of detection of testosterone abuse by gas chromatography/combustion/ isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrometry 1996;31:169-76.
  171. Hudson JI, Pope HG Jr. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am 1996;22:285-303.
  172. Gruber AJ, Hudson JI, Pope HG Jr. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine: fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am 1996;19:351-69.
  173. Kouri EM, Pope HG Jr, Oliva PS. Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate. Clin J Sport Med 1996;6:152-7.
  174. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, Strakowski SM. Are impulse control disorders related to bipolar disorder? Compr Psychiatry 1996;37:229-40.
  175. Hudson JI, Carter WP, Pope HG Jr. Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines. J Clin Psychiatry 1996;57[suppl 8]:73-9.
  176. Mialet J-P, Pope HG Jr, Yurgelun-Todd D. Impaired attention in depressive states: a non-specific deficit. Psychol Med 1996;26:1009-20.
  177. Pope HG Jr, Kouri EM, Powell KF, Campbell C, Katz DL. Anabolic-androgenic steroid use among 133 prisoners. Compr Psychiatry 1996;37:322-7.
  178. Hudson JI, Pope HG Jr, Carter WP, Daniels SR. Fibromyalgia, psychiatric disorders, and assessment of the long-term outcome of eosinophilia-myalgia syndrome. J Rheumatol 1996;(suppl 46) 23:37-43.
  179. Mangweth B, Pope HG Jr, Hudson JI, Biebl W. Bulimia nervosa in Austria and the United States: a controlled cross-cultural study. Int J Eat Disord 1996;20:263-70.
  180. Mialet J-P, Bisserbe JC, Jacobs A, Pope HG Jr. Two-dimensional anxiety: a confirmation using computerized neuropsychological testing of attentional performance. Eur Psychiatry 1996;11:344-52.
  181. Gruber AJ, Pope HG Jr, Brown ME. Do patients use marijuana as an antidepressant? Depression 1996;4:77-80.
  182. Ghaemi SN, Hebben N, Stoll AL, Pope HG Jr. Neuropsychological aspects of lack of insight in bipolar disorder: a preliminary report. Psychiatry Res 1996;65:113-20.
  183. Suppes T, Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson JI, Pope HG Jr. Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affective Disorders 1996;41:55-8.
  184. Gruber AJ, Pope HG Jr, Oliva PS. Very long-term users of marijuana in the United States: a pilot study. Subst Use Misuse 1997;32:249-64.
  185. Kouri EM, Pope HG Jr, Powell KF, Oliva PS, Campbell C. Drug use history and criminal behavior in 133 incarcerated men. Am J Drug Alcohol Abuse 1997;23:413-9.
  186. Pope HG Jr, Jacobs A, Mialet J-P, Yurgelun-Todd D, Gruber S. Evidence for a sex- specific residual effect of cannabis on visuospatial memory. Psychother Psychosom. 1997;66:179-84.
  187. Mangweth B, Pope HG Jr, Hudson JI, Olivardia R, Kinzl J, Biebl W. Eating disorders in Austrian men: an intra-cultural and cross-cultural comparison study. Psychother Psychosom 1997;66:214-21.
  188. Pope HG Jr, Gruber AJ, Choi PY, Olivardia R, Phillips KA. Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics 1997;38:548-57.
  189. Anfang MK, Pope HG Jr. Treatment of neuroleptic-induced akathisia with nicotine patches. Psychopharmacology 1997;134:153-6.
  190. Mangweth B, Pope HG Jr, Ionescu-Pioggia M, Kinzl J, Biebl W. Drug use and lifestyle among college students in Austria and the United States. Subst Use Misuse 1997;32:461- 73.
  191. Hudson JI, Chase EA, Pope HG Jr. Eye movement desensitization and reprocessing in eating disorders: caution against premature acceptance. Int J Eat Disord 1998;23: 1-5.
  192. Pope HG Jr, Hudson JI, Bodkin JA, Oliva P. Questionable validity of ‘dissociative amnesia’ in trauma victims. Evidence from prospective studies. Br J Psychiatry 1998;172:210-5.
  193. Klitzman R, Bodkin JA., Pope, HG Jr. Sexual orientation and associated characteristics among North American academic psychiatrists. J Sex Res 1998;35:282-7.
  194. Gruber AJ, Pope HG Jr. Ephedrine abuse among 36 female weightlifters. Am J Addictions 1998;7:256-61.
  195. Hudson, JI, McElroy SL, Raymond NC, Crow S, Keck PE Jr, Carter WP, Mitchell JE, Strakowski SM, Pope HG Jr, Coleman B, Jonas JM. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled double-blind trial. Am J Psychiatry 1998;155:1756-62.
  196. Halpern JH, Pope HG Jr. Do hallucinogens cause residual neuropsychological toxicity? Drug Alcohol Depend 1999;53:247-56.
  197. Pope HG Jr, Oliva PS, Hudson JI, Bodkin JA, Gruber AJ. Attitudes towards DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. Am J Psychiatry 1999;156:321-3.
  198. Kouri EM, Pope HG Jr, Lukas SE. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 1999;143:302-8
  199. Pope HG Jr, Olivardia R, Gruber A, Borowiecki J. Evolving ideals of male body image as seen through action toys. Int J Eat Disord 1999;26:65-72.
  200. Wines JD Jr, Gruber AJ, Pope HG Jr, Lukas SE. Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addictions 1999;8:161-4.
  201. Gruber AJ, Pope HG Jr. Compulsive weightlifting and anabolic drug abuse among women rape victims. Compr Psychiatry 1999;40:23-7.
  202. Mangweth B, Hudson JI, Pope HG Jr, Oberleit S, DeCol C, Kinzl J, Biebl W. Knowledge of calories and its effect on eating behavior in overweight, normal weight, and underweight individuals. Eating Weight Disord 1999; 4:165-8.
  203. Aguilera R, Catlin DH, Becchi M, Phillips A, Wang C, Swerdloff RS, Pope HG, Hatton CK. Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols. J Chromatography B 1999;727:95-105.
  204. Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000;69:19-26.
  205. Pope HG Jr., Kouri EM, Hudson JI. The effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 2000;57:133-40.
  206. Klitzman RL, Pope HG Jr, Hudson JI. MDMA (”ecstasy”) abuse and high-risk sexual behaviors among 169 gay men and bisexual men. Am J Psychiatry 2000;157:1162-4.
  207. Olivardia R, Pope HG Jr, Hudson JI. ‘Muscle dysmorphia’ in male weightlifters: a case-control study. Am J Psychiatry 2000;157:1291-6.
  208. Pope HG Jr, Gruber AJ, Mangweth B, Bureau B, deCol C, Jouvent R, Hudson JI. Body image perception among men in three countries. Am J Psychiatry 2000;157:1297-301.
  209. Gruber AJ, Pope HG, Borowiecki JJ, Cohane G. The development of the somatomorphic matrix: a bi-axial instrument for measuring body image in men and women. In K. Norton, T. Olds and J. Dollman (Eds.). Kinanthropometry VI. Adelaide: International Society for the Advancement of Kinanthropometry, pp. 217-231, 2000.
  210. Kouri EM, Pope HG Jr. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharm. 2000;8:483-492.
  211. Bowden CL, Calabrese JR, McElroy SL, Hirschfeld RMA, Petty F, Gyulai L, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Wozniak PJ. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481-489.
  212. Piper A Jr, Pope HG Jr, Borowiecki JJ. Custer’s last stand: Brown, Scheflin, and Whitfield’s latest attempt to salvage “dissociative amnesia.” J Psychiatry Law 2000;28 Summer:149-213.
  213. Leit RA, Pope HG Jr, Gray JJ. Cultural expectations of muscularity in men: the evolution of Playgirl centerfolds. Int J Eating Disord 2001;29:90-3.
  214. Mangweth B, Pope HG Jr, Kemmler G, Ebenbichler C, Hausmann A, DeCol C, Kinzl J, Biebl W. Body image and psychopathology in male bodybuilders. Psychother Psychosom 2001;70:38-43.
  215. Hudson JI, Laird NM, Betensky RA, Keck PE Jr, Pope HG Jr. Multivariate logistic regression for familial aggregation of two disorders: II. Analysis of studies of eating and mood disorders. Am J Epidemiology 2001;153:506-14.
  216. Halpern JH, Pope HG Jr. Hallucinogens on the internet: a vast new source of “underground”drug information. Am J Psychiatry 2001;158:481-3.
  217. Cohane GH, Pope HG Jr. Body image in boys: a review of the literature. Int J Eating Disord. 2001;29:373-9.
  218. Kanayama G, Gruber AJ, Pope HG Jr, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom 2001;70:137-40.
  219. Lalonde JK, Hudson JI, Gigante RA, Pope HG Jr. Canadian and American Psychiatrists’ attitudes toward dissociative disorders diagnoses. Can J Psychiatry 2001;46:407-12.
  220. Pope HG, Jr., Olivardia R, Borowiecki JJ, Cohane GH. The growing commercial value of the male body: a longitudinal survey of advertising in women’s magazines. Psychother Psychosom 2001;70:189-92.
  221. Cannell J, Hudson JI, Pope HG Jr. Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law 2001;29:138-47.
  222. Gruber AJ, Pope HG Jr, Lalonde JK, Hudson JI. Why do young women diet? The roles of body fat, body perception, and body ideal. J Clin Psychiatry 2001;62:609-11.
  223. Pope HG Jr, Ionescu-Pioggia M, Pope KW. Drug use and lifestyle among college undergraduates: a 30-year longitudinal study. Am J Psychiatry 2001;158:1519-21.
  224. Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001;58:909-15.
  225. Negus SS, Pope HG Jr, Kanayama G, Wines JD Jr, Fischer B. Lack of evidence for opioid tolerance or dependence in rhesus monkeys following high-dose anabolic-androgenic steroid administration. Psychoneuroendocrinology 2001;26:789-96.
  226. Leit, RA, Gray JJ, Pope HG Jr, The media’s representation of the ideal male body: A cause for muscle dysmorphia? Int J Eating Disord 2002;31:334-8.
  227. Choi PYL, Pope HG, Jr, Olivardia R. Muscle dysmorphia: a new syndrome in weightlifters. Br J Sportsmed 2002;36:375-7.
  228. Lipinski JP, Pope HG Jr. Body ideals in young Samoan men: a comparison with men in North America and Europe. Int J Men Health 2002;1:163-71.
  229. Pope HG Jr., Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Cognitive measures in long-term cannabis users. J Clin Pharmacol 2002;42:41S-47S.
  230. Pope HG Jr., Kanayama G, Cohane G, Siegel A, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized placebo-controlled trial. Am J Psychiatry 2003;160:105-11.
  231. Hudson JI, Mangweth B, Pope HG Jr, DeCol C, Hausmann A, Gutweniger S, Laird NM, Biebl W, Tsuang MT. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003;60:170-7.
  232. Kanayama G, Cohane G, Weiss RD, Pope HG Jr. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment an underrecognized problem? J Clin Psychiatry 2003;64:156-60.
  233. Halpern JH, Pope HG Jr. Hallucinogen persisting perception disorder: What do we know after 50 years? Drug Alcohol Depend 2003;69:109-19.
  234. Pope HG Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 2003;69:303-10.
  235. Kanayama G, Pope HG Jr, Cohane G, Hudson, JI. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend 2003;71:77-86.
  236. Carter WP, Hudson JI, Lalonde JK, Pindyck L, McElroy SL, Pope HG Jr. Pharmacologic treatment of binge eating disorder. Int J Eating Disord 2003;34:S74-S88.
  237. Mangweth B, Hudson JI, Pope HG Jr, Hausman A, De Col C, Laird NM, Biebl W, Tsuang MT. Family study of the aggregation of eating disorders and mood disorders. Psychol Med 2003;33:1319-23.
  238. Gruber AJ, Pope HG Jr, Hudson JI, Yurgelun-Todd, D. Attributes of long-term heavy cannabis users: a case-control study. Psychol Med 2003;33:1415-22.
  239. Mangweth B, Hausmann A, Walch T, Hotter A, Rupp CI, Biebl W, Hudson JI, Pope HG Jr. Body fat perception in eating disordered men. Int J Eating Disord 2004;35:102-08.
  240. Halpern JH, Pope HG Jr, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 2004;75:135-47.
  241. Olivardia R, Pope HG Jr, Borowiecki III JJ, Cohane GH. Biceps and body image: The relationship between muscularity and self-esteem, depression, and eating disorder symptoms. Psychology of Men and Masculinity 2004;5:112-20.
  242. Pope HG Jr, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid users’ attitudes towards physicians. Addiction 2004;99:1189-94.
  243. Hudson JI, Arnold LM, Keck PE Jr, Auchenbach MB, Pope HG Jr. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004;56:884-91.
  244. Hausmann A, Mangweth B, Walch T, Rupp C, Pope HG Jr. Body-image dissatisfaction in gay vs. heterosexual men: is there really a difference? J Clin Psychiatry 2004;65:1555-8.
  245. Pillay SS, Rogowska J, Kanayama G, Jon D, Gruber S, Simpson N, Cherayil M, Pope HG Jr, Yurgelun-Todd DA. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. Drug & Alcohol Dependence 2004;76:261-71.
  246. Yang CF, Gray P, Pope HG Jr. Male body image in Taiwan vs. the West: Yanggang Zhiqi meets the Adonis complex. Am J Psychiatry 2005;162:263-269.
  247. Kanayama G, Rogowska J, Pope HG Jr, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: an fMRI study. Psychopharmacology 2004; 176:239-47.
  248. Hudson JI, Pope HG Jr, Glynn RJ. The cross-sectional cohort study: an under-utilized design. Epidemiology 2005;16:355-9.
  249. Campbell BC, Pope HG Jr, Filiault S. Body image among Ariaal men from Northern Kenya. J Cross-Cultural Psychology 2005;36:371-379.
  250. Tzilos GK, Cintron CM, Woods J, Young AD, Simpson NS, Pope HG Jr, Yurgelun-Todd DA. Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addictions 2005;14:64-72.
  251. Halpern JH, Sherwood AR, Hudson, JI, Yurgelun-Todd D, Pope HG Jr. Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry, 2005;58:624-631.
  252. Pope CG, Pope HG Jr, Menard W, Fay C, Olivardia R, Phillips KA. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image 2005;2:395-400.
  253. Mangweth B, Hausmann A, Danzl C, Walch T, Rupp CI, Biebl W, Hudson JI, Pope HG Jr. Childhood body-focused behaviors and social behaviors as risk factors of eating disorders. Psychother Psychosom 2005;74:247-53.
  254. Pope HG Jr, Barry S, Bodkin JA, Hudson JI. Tracking a scientific interest in the dissociative disorders: a study of scientific publication output from 1984-2003. Psychother Psychosom 2006;75:19-24.
  255. Gray P,Yang CF, Pope HG Jr. Fathers have lower salivary testosterone levels than unmarried men and married non-fathers in Beijing, China. Proceedings of the Royal Society B 2006;273:333-9.
  256. Hudson JI, Lalonde JK, Berry JM, Pindyck LJ, Bulik CM, Crow SJ, McElroy SL, Laird NM, Tsuang MT, Walsh BT, Rosenthal NR, Pope HG Jr. Binge eating disorder as a distinct familial phenotype in obese individuals. Arch Gen Psychiatry 2006;63:313-9.
  257. Kanayama G, Barry S, Hudson JI, Pope HG Jr. Body image, self-esteem, and attitudes towards male roles in anabolic-androgenic steroid users. Am J Psychiatry 2006;163:697-703.
  258. Sewell R, Halpern JH, Pope HG Jr. Response of Cluster Headache to Psilocybin and LSD. Neurology 2006; 66:1920-1922.
  259. Pope HG Jr, Lalonde JK, Pindyck LJ, Walsh BT, Bulik CM, Crow SJ, McElroy SL, Rosenthal N, Hudson JI. Binge eating disorder: a stable syndrome. Am J Psychiatry 2006;163:2181-83.
  260. Sneider JT, Pope HG Jr, Silveri MM, Gruber SA, Rogowska J, Yurgelun-Todd DA. Altered regional blood volume in chronic cannabis smokers. Exp Clin Psychopharm 2006;14:422-8.
  261. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007;61:348-58.
  262. Pope HG Jr, Poliakaoff MB, Parker MP, Boynes M, Hudson JI. Is dissociative amnesia a cultural artifact? Findings from a survey of historical literature. Psychological Med 2007;37:225-33.
  263. Bodkin JA, Pope HG, Detke MJ, Hudson JI. Is PTSD caused by traumatic stress? J Anx Disord 2007;21:176-82.
  264. Kanayama G, Boynes M, Hudson JI, Field AE, Pope HG Jr. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend 2007;88:156-62.
  265. Brendel DH, Chu J, Radden J, Leeper H, Pope HG, Samson J, et al. The price of a gift: an approach to receiving gifts from patients in psychiatric practice. Harvard Rev Psychiatry 2007;15:43-51.
  266. Choi-Kain LW, Pope HG. “Atypical” Neuroleptic Malignant Syndrome and the spectrum of malignant cerebrotoxic syndromes. Harvard Rev Psychiatry 2007;15:181-86.
  267. Kanayama G, Amiaz R, Seidman S, Pope HG Jr., Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp Clin Psychopharm 2007;15:529-38.
  268. Javaras KN, Laird NM, Reichborn-Kjennerud T, Bulik CM, Pope HG Jr, Hudson, JI. Familiarity and heritability of binge eating disorder: results of a case-control family study and a twin study. Int J Eat Disord 2008;41:174-79.
  269. Pillay SS, Rogowska J, Kanayama G, Duk-In J, Gruber S, Simpson N, Cherayil M, Pope HG Jr., Yurgelun-Todd D. Cannabis and Motor Function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharm 2008;16:22-32.
  270. Hudson JI, Javaras KN, Laird NM, VanderWeele TJ, Pope HG Jr, Hernan MA. A structural approach to the familial coaggregation of disorders. Epidemiology 2008;19:431-439.
  271. Schneider, JT, Pope, HG Jr., Silveri, MM, Simpson, NS, Gruber, SA, & Yurgelun-Todd, DA. Differences in Regional Blood Volume During a 28-Day Period of Abstinence in Chronic Cannabis Smokers. European Neuropsychopharmacology, in press.
  272. Yang CF, Gray PB, Zhang J, Pope HG Jr. Second to fourth digit ratios, sex differences, and behavior in Chinese men and women. Soc Neuroscience 2008;99999(1):1-11
  273. Yang CF, Hooven CK, Gray PB, Boynes M, Pope HG Jr. Testosterone levels and mental rotation performance in Chinese men. Horm Behavior 2007;51(3):373-8.
  274. Javaras KN, Pope HG Jr., Lalonde JK, Roberts JL, Nillni YI, Laird NM, Bulik CM, Crow SJ, McElroy SL, Walsh BT, Tsuang MT, Rosenthal. NR, Hudson JI. Co-Occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry 2008;69(2):266-73.

Proceedings of Meetings:

  1. Hudson JI, Pope HG Jr, Jonas JM. Bulimia: A form of affective disorder? American Psychiatric Association Annual Meeting, New York, May 5, 1983.
  2. Hudson JI, Pope HG Jr, Jonas JM. Antidepressant treatment of bulimia. In symposium, Bulimia: Integrating Assessment and Treatment. World Congress on Behavior Therapy, Washington, DC, December 12, 1983.
  3. Pope HG Jr, Hudson JI, Jonas JM, Frankenburg FR, Yurgelun-Todd D. Prevalence of atypical depression and borderline personality disorder in bulimia: a controlled study. American College of Neuropsychopharmacology Annual Meeting, December 13, 1983.
  4. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D, Frankenburg F. Family history comparison of active and remitted bulimic patients. First International Conference on Eating Disorders, New York, April 8, 1984, Abs. 111.
  5. Hudson JI, Pope HG Jr, Yurgelun-Todd D, Jonas JM, Frankenburg F. Typical versus “atypical” depression in bulimia. First International Conference on Eating Disorders, April 8, 1984, Abs. 112.
  6. Hudson JI, Hudson MS, Goldenberg DL, Pliner LF, Pope HG Jr. Fibrositis related to major affective disorder. American Psychiatric Association Annual Meeting, Los Angeles, May 8, 1984, NR44.
  7. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D, Frankenburg FR. Affective symptoms in bulimia: A controlled study. American Psychiatric Association Annual Meeting, Los Angeles, May 8, 1984, NR45.
  8. Jonas JM, Pope HG Jr, Hudson JI, Cohen BM. Psychosis in borderlines: An empirical study. American Psychiatric Association Annual Meeting, Los Angeles, May 8, 1984, Paper No. 24.
  9. Pope HG Jr, Hudson JI, Jonas JM. Treatment of bulimia with antidepres-sants. American Psychiatric Association Annual Meeting, Los Angeles, May 10, 1984, Symposium 76E.
  10. Hudson JI, Jonas JM, Pope HG Jr, Stakes J, Grochochinski V. Sleep EEG in bulimia. American Psychiatric Association Annual Meeting, Dallas, May 22, 1985, NR 141.
  11. Pope HG Jr, Herridge PL, Hudson JI, Fontaine R, Yurgelun-Todd D. Treatment of bulimia with nomifensine. American Psychiatric Association Annual Meeting, Dallas, May 22, 1985, NR 143.
  12. Jonas JM, Pope HG Jr, Hudson JI, Cohen BM, Tohen M. Psychosis in borderline personality disorder. Fourth Annual World Congress of Biological Psychiatry, Philadelphia, September 11, 1985.
  13. Pope HG Jr, Hudson JI, Yurgelun-Todd D, Jonas JN, Frankenburg FR. Phenomenology and family history of patients with eating disorders. Second International Conference on Eating Disorders, Sydney, Australia, March 17, 1986.
  14. Pope HG Jr, Hudson JI. Treatment of bulimia with antidepressants. Second International Conference on Eating Disorders, Sydney, Australia, March 17, 1986.
  15. Pope HG Jr. Treatment of bulimia with antidepressants. Second International Conference Eating Disorders, New York, April 19, 1986.
  16. Hudson JI, Pope HG Jr, Wurtman J, Yurgelun-Todd D, Mark S, Rosenthal N. Bulimia and obesity. Second International Conference on Eating Disorders, New York, April 20, 1986.
  17. Pope HG Jr, Hudson, JI, Yurgelun-Todd D, Jonas JM, Frankenburg FR. Phenomenology and family history of patients with eating disorders. Second International Conference on Eating Disorders, New York, April 20, 1986.
  18. Hudson JI, Pope HG Jr, Jonas JM. Sleep EEG in bulimia. American Psychiat-ric Association Annual Meeting, Washington, DC, May 12, 1986.
  19. Hudson JI, Pope HG Jr, Yurgelun-Todd D, Jonas JM. Bulimia and antidepressants: a two-year follow-up. American Psychiatric Association Annual Meeting, Washington, DC, May 13, 1986.
  20. Pope HG Jr. Treatment of bulimia with antidepressants. American Psychiatric Association Annual Meeting, Washington, DC, May 13, 1986.
  21. Pope HG Jr, Caroff SN. Neuroleptic malignant syndrome (symposium). American Psychiatric Association Annual Meeting, Washington, DC, May 15, 1986.
  22. Hudson JI, Pope HG Jr. Newer antidepressants in the treatment of bulimia nervosa. NCDEU Annual Meeting, May, 1986.
  23. McElroy SM, Pope HG Jr, Keck PE Jr, Hudson JI. Treatment of primary psychiatric disorders with sodium valproate: a series of 73 cases. American Psychiatric Association Annual Meeting, Chicago, May 11, 1987.
  24. Katz DL, Pope HG Jr. Psychiatric effects of anabolic steroids. Ross Laboratories Conference on Nutritional Alternatives to Anabolic Steroids, Charleston, S.C., September 28, 1987.
  25. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI. Treatment of psychiatric disorders with sodium valproate: a series of 73 cases. Hospital and Community Psychiatry Annual Meeting, Boston, MA, October 26-28, l987.
  26. Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI. Treatment of bulimia nervosa with trazodone: a placebo-controlled, double-blind study. Third International Conference on Eating Disorders, New York, April 23, l988.
  27. Hudson JI, Hudson MS, Zierk KC, Pope HG Jr. Urine pH as a marker for bulimia nervosa. Third International Conference on Eating Disorders, New York, April 23, l988.
  28. Pope HG Jr. Anticonvulsants in psychiatry: recent advances (symposium). American Psychiatric Association Annual Meeting, Montreal, May 8, 1988.
  29. Hudson JI, Pope HG Jr, Keck PE Jr, McElroy SL. A placebo-controlled study of trazodone in bulimia nervosa. XVIth Congress of the Collegium Internationale Neuro- Psychopharmacologicum, Munich, August 15, 1988.
  30. Katz DL, Pope HG Jr. Psychiatric side effects of anabolic steroids. World Psychiatric Association, Regional Symposium, Washington, DC, October 15, 1988.
  31. Pope HG Jr, Katz DL. Psychiatric effects of anabolic steroids. American Public Health Association Annual Meeting, Boston, Nov. 12, 1988.
  32. Katz DL, Pope HG Jr. Anabolic steroid-induced mental status changes. National Institute of Drug Abuse Technical Review Meeting, Rockville MD, March 7, 1989.
  33. Enas GG, Pope HG Jr, Levine LE, Ballenger JC, Blinder BJ, Dixon K, Dunlop SR, Goldbloom D, Ferguson JM, Halikas J, Herzog DB, Hsu LKG, Hudson JI, Powers PS, Reinher FW, Yates WR, and the Fluoxetine Bulimia Collaborative Study Group. Fluoxetine in bulimia nervosa: double-blind study. American Psychiatric Association Annual Meeting, San Francisco, May 11, 1989.
  34. Gutierrez-Esteinou R, Pope HG Jr. Does fluoxetine prolong electrically induced seizures? New Drug Clinical Evaluation Unit Annual Meeting, Key Biscayne, May 31, 1989.
  35. Katz DL, Pope HG Jr. Les effets contraires psychologiques et psychiatriques du dopage aux steroides androgenes et anabolisants. Second International Athletic Foundation World Symposium on Doping in Sport, Monte Carlo, June 6, 1989.
  36. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania: a placebo-controlled study. American Psychiatric Association Annual Meeting, New York, May 15, 1989.
  37. Nierenberg AA, Keck PE Jr, Pope HG Jr, Vukovic AA. Monoamine oxidase inhibitor autoinduction of hypertension without crisis. World Psychiatric Association Regional Symposium, Washington, DC, October 13, 1989.
  38. Ionescu-Pioggia M, Pope HG Jr. College undergraduate drug use and lifestyle: a comparison - 1969, 1978, and 1989. College on Problems of Drug Dependence, Washington, DC, June 11, 1990.
  39. Goldenberg DL, Hudson JI, Keck PE Jr, Pope HG Jr. Depression, panic disorder, migraine, and irritable bowel syndrome in fibromyalgia syndrome. Presented at the 54th Annual Scientific Meeting of the American College of Rheumatology, Seattle, October, 1990.
  40. Pope HG Jr, Ionescu-Pioggia M, Aizley H, Varma DK. Drug use and life style among college undergraduates in 1989: a comparison with 1969 and 1978. Abstract-a-Card, Psychiatry Edition, Volume 1, Number 4, December, 1990.
  41. Pope HG Jr. Tabernanthe iboga: an African narcotic of social importance. Truth Seeker 1990; 117:28-33.
  42. Hudson JI, Pope HG Jr. Anxiety and depression: Common diathesis? American Psychiatric Association Annual Meeting, New Orleans, May, 1991.
  43. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. 55th Annual Meeting of the American College of Rheumatology, Boston, November 1991.
  44. Bodkin JA, Klitzman RL, Pope HG Jr. Distinctions between biological psychiatrists and psychotherapists. American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, December, 1991.
  45. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda G. What is dysphoric mania? American Psychiatric Association Annual Meeting, Washington, DC, May, 1992.
  46. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: 50 cases of imagined ugliness. American Psychiatric Association Annual Meeting, Washington, DC, May, 1992.
  47. McElroy SL, Phillips KA, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: can it be psychotic? American Psychiatric Association Annual Meeting, Washington, DC, May, 1992.
  48. Pope HG Jr, Katz DL, Aizley HG. Psychiatric symptoms in anabolic steroid users. American Psychiatric Association Annual Meeting, Washington, DC, May, 1992.
  49. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson, Faedda GL, Swann AC. Dysphoric or mixed mania: Clinical and theoretical implications of mania accompanied by depression. Second International Conference on Refractory Depression. Amsterdam, The Netherlands, June 24-26, 1992.
  50. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: 74 cases of imagined ugliness. First International Obsessive Compulsive Disorder Conference Abstracts. Weesp, The Netherlands: Solvay Duphar, 1993;85-86.
  51. Ghaemi NS, Stoll AL, Pope HG Jr. Insight in mania. Presented at Boston Society of Neurology and Psychiatry Stanley Cobb Assembly, Boston 25 March 1993.
  52. Ghaemi NS, Stoll AL, Pope HG Jr. Insight in mania. Harvard Department of Psychiatry Research Day, Harvard Medical School, Boston, MA, April 21, 1993.
  53. Tohen MT, Castillo J, Pope HG Jr, Herbstein J. Concomitant use of of valproate and carbamazepine in bipolar and schizoaffective disorder. American Psychiatric Association Annual Meeting, San Francisco, CA, May, 1993.
  54. Ghaemi NS, Stoll, AL, Pope HG Jr. Insight in mania. American Psychiatric Association Annual Meeting, San Francisco, May, 1993.
  55. Zornberg G, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. Harvard Department of Psychiatry Research Day, Harvard Medical School, Boston, MA, April 21, 1993.
  56. Gruber A, Pope HG, Jr. Cannabis psychotic disorder: does it exist? Harvard Department of Psychiatry Research Day, Harvard Medical School, Boston, MA, April, 1993.
  57. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: can it be psychotic? Harvard Department of Psychiatry Research Day, Harvard Medical School, Boston, MA, April, 1993.
  58. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: can it be psychotic? American Psychiatric Association Annual Meeting, San Francisco, May, 1993.
  59. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: 90 cases of imagined ugliness. American Psychiatric Association Annual Meeting, San Francisco, May, 1993.
  60. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: can it be psychotic? NCDEU Annual Meeting, Boca Raton, FL, June 3, 1993; Psychopharm Bull 1994;30:119.
  61. Hudson JI, Pope HG Jr. Is childhood sexual abuse a risk factor for bulimia? American Psychiatric Association Annual Meeting, San Francisco, CA, May, 1993.
  62. Choi PYL, Pope HG Jr. Violence towards women and illicit anabolic-androgenic steroid use in strength athletes. The Annual Conference of the British Association of Sports Sciences. Didsbury, Manchester, England, November 1993.
  63. Carter WP, Hudson JI, Pope HG Jr, McElroy SL, Mitchell JE, Kim JM, Jonas JM. Fluvoxamine in binge eating disorder: a controlled trial. Harvard Department of Psychiatry Research Day, Harvard Medical School, Boston, MA March 10, 1994.
  64. Kosche MA, Pope HG Jr. Treatment of drug-induced akathisia with nicotine patch. Harvard Department of Psychiatry Research Day, Harvard Medical School, Boston, MA March 10, 1994.
  65. Hudson JI, McElroy SL, Raymond N, Crow S, Keck PE Jr, Carter WP, Mitchell J, Strakowski S, Pope HG Jr, Coleman B, Jonas JM. Fluvoxamine in the treatment of binge eating disorder: a multicenter, placebo-controlled study. Sixth International Conference on Eating Disorders, New York, April, 1994.
  66. Pope HG Jr, Mangweth B, Negrao A, Hudson JI, Cordas T. Childhood sexual abuse and bulimia nervosa: a comparison of American, Austrian and Brazilian Women. Sixth International Conference on Eating Disorders, New York, April, 1994.
  67. Mangweth B, Pope HG Jr, Hudson JI. Bulimia nervosa in two cultures: a comparison of Austrian and American college students. Sixth International Conference on Eating Disorders, New York, April, 1994.
  68. Pope HG Jr, Mangweth B, Negrao AB, Hudson JI, Cordas TA. Child sex abuse and bulimia in 3 countries. American Psychiatric Association Annual Meeting, Philadelphia, May, 1994.
  69. Phillips KA, McElroy SL, Keck PE Jr, Hudson JI, Pope HG Jr, Atala KD. Body dysmorphic disorder: can it be psychotic? CME Syllabus and Proceedings, American Psychiatric Association 147th Annual Meeting, Philadelphia: American Psychiatric Association, 1994:114
  70. Phillips KA, McElroy SL, Gunderson CG, Mallya G, Atala KD, Pope HG Jr, Hudson JI. body dysmorphic disorder: data on imagined ugliness. CME Syllabus and Proceedings, American Psychiatric Association 147th Annual Meeting, Philadelphia: American Psychiatric Association, 1994:299.
  71. Phillips KA, McElroy SL, Atala KD, Keck PE, Jr, Hudson, JI, Pope HG Jr. Body dysmorphic disorder: obsessive compulsive or affective spectrum disorder? CME Syllabus and Proceedings, American Psychiatric Association 147th Annual Meeting. Philadelphia: American Psychiatric Association 1994:289.
  72. Kouri EM, Pope HG Jr, Katz DL. A new method to screen for anabolic steroid abuse. American Psychiatric Association Annual Meeting, Philadelphia, May 1994.
  73. Hudson JI, Pope HG Jr. Evidence for “affective spectrum disorder.” XIXth Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Washington, DC, July, 1994.
  74. Phillips KA, Atala KD, Pope HG Jr. Diagnostic instruments for body dysmorphic disorder. New Reserach Program and Abstracts, American Psychiatric Association 148th Annual Meeting. Miami: American Psychiatric Association, 1995:157.
  75. Kouri EM, Lukas SE, Pope HG Jr, Oliva PS. Effects of supraphysiologic doses of testosterone on aggressive and non-aggressive responding. College on Problems of Drug Dependence, Scottsdale AZ, June 1995.
  76. Pope HG Jr, Katz DL. Aggression: a psychiatric effect of the anabolic-androgenic steroid. European College of Neuropsychopharmacology Annual Meeting, Venice, Italy, September, 1995.
  77. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD, Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Onset of antimanic effect with divalproex. American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, December, 1995.
  78. Mangweth B, Pope HG Jr, Hudson JI, Olivardia R, Kinzl J. Eating disorders in Austrian men: an intra-cultural and cross-cultural comparison study. Seventh International Conference on Eating Disorders, New York, April, 1996.
  79. Hudson JI, Chase, EA, Pope HG Jr. Eye movement desensitization and reprocessing (EMDR) in eating disorders: caution against premature acceptance. Seventh International Conference on Eating Disorders, New York, April, 1996.
  80. Pope HG Jr, Katz DL. Psychiatric effects of exogenous anabolic/androgenic steroids. American Psychiatric Association Annual Meeting, New York, May, 1996.
  81. Kouri EM, Pope HG Jr, Lukas SE, Oliva PS. Effects of anabolic steroids on aggressive responding in humans: is there a dose-response? College on Problems of Drug Dependence, San Juan, Puerto Rico, June, 1996.
  82. Kouri EM, Pope HG Jr, Oliva PS. Psychiatric effects of increasing doses of testosterone cypionate in male volunteers. American Psychological Association Annual Meeting, Toronto, Canada, August 1996.
  83. Kouri EM, Pope HG Jr, Oliva PS. Behavioral and psychiatric effects of testosterone cypionate injections in men. American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, December, 1996.
  84. Kouri EM, Pope HG Jr, Lukas SE. Changes in aggressive behavior following discontinuation from long-term marihuana use. College on Problems of Drug Dependence 59th Annual Meeting, Nashville, Tennessee, June, 1997.
  85. Halpern JH, Pope HG. Neurocognitive deficits in a peyote consuming population. The Young Investigators’ Research Colloquium of the 150th Annual Meeting of the American Psychiatric Association, San Diego, CA, 5/18/97.
  86. Mangweth B, Thiel A, Biebl W, Kinzl J, Hudson JI, Pope HG Jr. Body image and psychopathology among male bodybuilders. Eighth New York International Conference on Eating Disorders, New York, April, 1998.
  87. Mangweth B, Kemmler G, Oberleit S, Kinzl J, Biebl W, Pope HG Jr, Hudson JI. Response to knowledge of calories among overweight versus normal weight individuals. Eighth International Conference on Eating Disorders, New York, April, 1998.
  88. Kouri EM, Pope HG Jr. Psychiatric effects of supraphysiologic doses of testosterone cypionate in males. Society of Biological Psychiatry Annual Meeting, Toronto, Canada, May , 1998.
  89. Street C, Gruber A, Pope HG Jr. Eating disorders, body image and drug use among dedicated resistance-trained females: preliminary impressions. American College of Sports Med, Orlando, Florida, June 1998. Med. Sci. Sports 30 (5): S341.1998.
  90. Kouri EM, Pope HG Jr, Lukas SE. Abstinence symptoms following discontinuation from long-term heavy marijuana use in humans. College on Problems of Drug Dependence, 60th Annual Meeting, Scottsdale, Arizona, June, 1998.
  91. Yurgelun-Todd DA, Gruber SA, Hanson RA, Baird AA, Renshaw PF, Pope HG Jr. Residual effects of marijuana use: an fMRI study. College on Problems of Drug Dependence, 60th Annual Meeting, Scottsdale, Arizona, June, 1998
  92. Gruber AJ, Pope HG Jr. Steroid use among women bodybuilders. Presented at the 44th meeting of the Community Epidemiology Work Group (CEWG) sponsored by the National Institute on Drug Abuse (NIDA) in Boston, MA, June 25, 1998.
  93. Gruber AJ, Pope HG Jr. Purpose and design of the somatomorphic matrix. Presented at the 1998 Australian Conference of Science and Medicine in Sport in Adelaide, Australia, October 13-16, 1998.
  94. Gruber AJ, Pope HG Jr. Steroid use among women bodybuilders. Presented at the 1998 Australian Conference of Science and Medicine in Sport in Adelaide, Australia, October 13-16, 1998.
  95. Hudson JI, Laird NM, Betensky RA, Pope HG Jr. Reanalysis of a family history study of bulimia nervosa and depression using multivariate binary response models. Eating Disorders Research Society Meeting, Boston MA, November 6, 1998.
  96. Mangweth B, Thiel A, Biebl W, Kinzl J, Hudson JI, Pope HG Jr. Eating behavior, body image, and psychopathology of male bodybuilders. Eating Disorders Research Society Meeting, Boston MA, November 6, 1998.
  97. Halpern JH, Pope HG Jr. Hallucinogens on the internet: a vast underground psychedelic resource. College on Problems of Drug Dependence, Acalpulco, Mexico, June, 1999.
  98. Gruber AJ, Pope HG Jr. Residual neuropsychological effects of cannabis. Presented at the 1999 Summer Meeting of the British Association for Psychopharmacology. July 28, 1999, Harrogate, England.
  99. Mangweth B, Pope HG Jr, Hudson JI, De Col C, Hausmann A, Gutweniger S, Kinzl J, Biebl W. A controlled family study of “affective spectrum disorder.” The XI World Congress of Psychiatry, August 8, 1999, Hamburg, Germany.
  100. Lalonde JK, Hudson JI, Gigante RA, Pope HG Jr. Attitudes of American and Canadian psychiatrists towards DSM-IV dissociative disorders diagnoses. 49th Annual Meeting of the Canadian Psychiatric Association, Toronto, September, 1999.
  101. Hudson JI. SSRI’s in the treatment of binge-eating disorder: placebo-controlled studies of fluvoxamine and sertraline. Eating Disorders Research Society Meeting, San Diego, November 19, 1999.
  102. Hudson JI, Mangweth B, Pope HG Jr, De Col C, Hausmann A, Gutweniger S, Kinzl J, Biebl W. Coaggregation of eating disorders and mood disorders in a family study of major depressive disorder. Eating Disorders Research Society Meeting, San Diego, November 20, 1999.
  103. Hudson JI, Laird NM, Betensky RA, Keck PE Jr, Pope HG Jr. Analysis of familial aggregation of eating and mood disorders with multivariate logistic regression models. Presented at the Ninth International Conference on Eating Disorders, New York, NY, May, 2000.
  104. Hudson JI, Mangweth B, Pope HG Jr, DeCol C, Hausmann A, Gutweniger S, Kinzl J, Biebl W. Coaggregation of eating and mood disorders in a family study of major depressive disorder. Presented at the Ninth International Conference on Eating Disorders, New York, NY, May, 2000.
  105. Lalonde JK, Gruber AJ, Pope Jr HG, Boroweicki JJ. Dieting and body image distortion in college-age women. Presented at the Academy for Eating Disorders Ninth International Conference, New York, May 5, 2000.
  106. Hudson JI, Betensky RA, Keck PE, Pope HG Jr. Familial aggregation of eating and mood disorders. American Psychiatric Association Annual Meeting, Chicago, Il. May 18, 2000.
  107. Lalonde JK, Hudson JI, Gigante RA, Pope HG Jr. Psychiatrists’ opinions on dissociative disorders. Presented at the American Psychiatric Association Annual Meeting, Chicago, May 15, 2000.
  108. Lalonde JK, Hudson JI, Gigante RA, Pope HG Jr. Cultural differences towards dissociative disorders. Presented at the World Psychiatric Association, International Congress, Paris, June 26, 2000.
  109. Pope HG Jr, Gruber AJ. Cognitive consequences of long term marijuana use. World Psychiatry Conference, Paris, France, June, 2000.
  110. Olivardia R, Pope HG Jr, Hudson JI. Muscle dysmorphia in male weightlifters. Presented at the American Psychiatric Association Annual Meeting, Chicago, IL May, 2000
  111. Earl N, Greene P, Ascher J, Fouche N, Chang C, Evoniuk G, Swann A, Pope HG Jr, McElroy S, Post R, Zajecka J, Altshuler L, Apter J, West S, Risch C, Khan A. Mood stabilization with lamotrigine in rapid cycling bipolar disorder. Presented at the European College of Neuropsychopharmacology, Munich, Germany, September, 2000.
  112. Halpern JH, Pope HG Jr, Sherwood A, Hudson JI, Yurgelun-Todd D. Neuropsychological effects of long-term hallucinogen use in Native Americans. Meeting of the College on Problems of Drug Dependence, Scottsdale, AZ. June 18, 2001.
  113. Pope HG Jr, Negus SS, Kanayama G. Lack of evidence for features of opioid dependence in monkeys receiving high-dose anabolic-androgenic steroids. Meeting of the College on Problems of Drug Dependence, Scottsdale, AZ. June 18, 2001
  114. Gruber SA, Killgore, WD, Renshaw, PF, Pope, HG Jr., Yurgelun-Todd, DA. Gender differences in cerebral blood volume after a 28-day washout period in chronic marijuana smokers. [Abstract]. Meeting of the College on Problems of Drug Dependence. Scottsdale, Arizona. June 2001.
  115. Yurgelun-Todd, DA, Simpson NS, Gruber SA, Renshaw PF, Pope, HG Jr. Cerebral Blood Volume Changes after a 28- Day Washout Period in Chronic Marijuana Smokers: A DSC-MRI Study. [Oral Presentation]. Meeting of the College on Problems of Drug Dependence. Scottsdale, Arizona. June 2001.
  116. Carter EJ, Wtsadik AT, Darwin WD, Pope HG Jr, Gruber, AJ, Huestis MA. Urinary excretion of 9-tetrahydrocannabinol (THC), 11-Hydroxy-THC (11-OH-THC), and 11-Nor-9-Carboxy-THC (THCCOOH) in long term marijuana users. Presented at the Society of Forensic Toxicologists, New Orleans, LA September 30-October 5, 2001.
  117. Bodkin JA, Pope HG, Hudson JI, Detke MJ, Carter WP, Cole JO. Does posttraumatic stress disorder occur only following traumatic stress? Presented at the American College of Neuropsychopharmacology meeting, Waikoloa, Hawaii, December 2001
  118. Pope HG, Jr, Kanayama G, Gruber AJ. Performance-enhancing dietary supplement use among men and women in American gymnasiums. Presented at National Institutes of Health Office of Dietary Supplements and Council for Responsible Nutrition Conference on the Science and Policy of Performance-Enhancing Products, NIH, Bethesda, MD. January 8, 2002.
  119. Pillay SS, Pope HG Jr, Gruber SA, Yurgelun-Todd DA. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. College on Problems of Drug Dependence; June 2002. Quebec City, Quebec. Drug Alcohol Depend 2002;66:S139.
  120. Young AD, Gruber SA, Killgore WDS, Pope HG Jr, Yurgelun DA. Age of onset is associated with decreased hippocampal volume in heavy cannabis users. College on Problems of Drug Dependence; June 2002. Quebec City, Quebec. Drug Alcohol Depend 2002;66:S199-S200.
  121. Halpern JH, Pope HG Jr, Sherwood A, Hudson JI, Yurgelun-Todd D. Neuropsychological effects of long-term hallucinogen use vs. alcoholism in Native Americans: cultural limitations of tests. College on Problems of Drug Dependence. June 2002 Quebec City, Quebec. Drug Alcohol Depend 2002;66:S73-S74.
  122. Simpson NS, Gruber SA, Pope HG Jr, Yurgelun-Todd DA. Cerebellar blood volume changes after a 7-day washout period in chronic marijuana smokers: a DSC-MRI study. College on Problems of Drug Dependence. June 2002, Quebec City, Quebec. Drug Alcohol Depend 2002;66:S166.
  123. Pope HG Jr, Kanayama G, Cohane GH, Siegel AJ, Hudson JI. Testosterone gel supplementation in treatment-refractory depressed men. American Psychiatric Association 54th Institute on Psychiatric Services. Chicago, IL October 11, 2002.
  124. Mangweth BM, Hudson JI, Pope HG Jr, Hausmann A, De Col C, Biebl W, Laird NM, Tsuang MT. Family study of the aggregation of eating disorders and mood disorders. Eating Disorders Research Society Meeting, Charleston, SC, November 2002.
  125. Kanayama G, Pope HG Jr, Cohane G, Hudson, JI. Risk factors for anabolic-androgenic steroid use among weightlifters. American Psychiatric Association, San Francisco, CA May 2003.
  126. Pillay SS, Kanayama G, Jon D, et al. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: An fMRI study [Abstract}. Society of Biological Psychiatry Annual Meeting, San Francisco, CA. May 2003.
  127. Pope HG Jr. Testosterone gel supplementation for men with refractory depression: a randomized placebo-controlled trial. 17th World Congress on Psychosomatic Medicine. Waikoloa, Hawaii. August , 2003.
  128. Pope HG Jr. Cannabis. Office of National Drug Control Policy Briefing. Washington, ONDCP, Oct 6, 2003.
  129. Pope HG Jr. Neurobiology of anabolic-androgenic steroids: clinical implications. American Association of Child and Adolescent Psychiatrists, Miami, Florida, October 17, 2003.
  130. Hudson JI, Pope HG Jr, Lalonde JK, Berry JM, Pindyck LJ, Cohane GH, Bulik CM, Crow SJ, Laird NM, McElroy SL, Tsuang MT, Walsh BT, Rosenthal NR. Family study of binge eating disorder: preliminary descriptive results. Presented at the Academy for Eating Disorders Annual Meeting, Orlando, FL, April 2004.
  131. Pope HG Jr, Yurgelun-Todd D. Cognitive toxicity of cannabis: the devil is in the confounding variables. American Psychiatric Association, New York, New York, May 2004.
  132. Pope HG Jr, Kanayama G. Underlying motivation and clinical side effects of anabolic androgenic steroid use. American Psychiatric Association, New York, New York, May 2004.
  133. Gray P, Campbell B, Yang CF, Pope HG Jr. Male body image in cross-cultural context: new data from Taiwan and Kenya. Presented at the 103rd Annual Meeting of the American Academy of Anthropology, San Francisco, CA, November, 2004.
  134. Hudson JI, Pope HG Jr, Lalonde JK, Pindyck LJ, Barry S, Vine MM, Bulik CM, Crow SJ, Laird NM, McElroy SL, Tsuang MT, Walsh BT, Rosenthal NR. Family study of binge eating disorder. Presented at Academy for Eating Disorders Meeting, Montreal, April 2005.
  135. Hudson JI, Pope HG Jr, Lalonde JK, Berry JM, Placidi RJ, Crow SJ, McElroy SL, Laird NM, Tsuang MT, Walsh BT, Bulik CM, Capece JA, Rosenthal NR. Familial factors for binge eating disorder. Biol Psychiatry 2005;57:141S.
  136. Pope HG Jr, Kanayama G. The fat-free body mass index calculation: how to bust the steroid user. Annual Meeting of the American Psychiatric Association Meeting, Atlanta, Georgia, May 26, 2005.
  137. Gray PB, Yang CF, Pope HG Jr. Fathers haver lower salivary testosterone levels than unmarried men and married non-fathers in Bejing, China. Presented at the Human Behavior and Evolution Society Meeting, Austin, TX. June 2005.
  138. Pope HG Jr. Widespread anabolic steroid use in American girls and women: an illusion? House Government Reform Committee, June 15, 2005, Washington, DC.
  139. Sneider JT, Pope HG, Silvery MM, Rosso IM, Gruber SA, Yurgelun-Todd DA. Altered regional blood volume in chronic marijuana smokers. Society of Neuroscience Poster UU95.
  140. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The epidemiology of eating disorders: results from the National Comorbidity Survey Replication. Presented at Eating Disorders Research Society Meeting, Toronto, September 2005.
  141. Hudson JI, Lalonde JK, Berry J, Bulik CM, Crow SJ, McElroy SL Laird NM, Tsuang MT, Walsh BT, Capece JA, Rosenthal NR, Pope HG Jr. Family study of binge eating Disorder. Presented at Eating Disorders Research Society Meeting, Toronto, September 2005.
  142. Hudson JI, Lalonde JK, Pindyck LJ, Walsh BT, Bulik CM, Crow SK, McElroy SL, Rosenthal NR, Pope HG Jr. Binge eating disorder: a stable syndrome. Presented at Eating Disorders Research Society Meeting, Toronto, September 2005.
  143. Pope HG. Psychopharmacological strategies in the treatment of psychotic and affective disorders: current practice in the United States. Presented at Kangning Hospital (Shenzhen Mental Health Institute), Shenzhen, China, November 11, 2005.
  144. Sneider JT, Pope HG, Silveri MM, Gruber SA, Rogowska J, Yurgelun-Todd DA. Changes in regional blood volume during a 28-day period of abstinenece in chronic cannabis smokers. College on Problems of Drug Dependence, Phoenix Arizona, June 2006.
  145. Javaras KN, Pope HG Jr, Lalonde JK, Nillni Y, Roberts J, Laird NM, Bulik CM, Crow, McElroy SL, Walsh BT, Rosenthal NR, Hudson JI. Comorbidity of binge eating disorder with psychiatric and medical disorders. Presented at Eating Disorders Research Society Meeting, Port Douglas, Australia, August 2006.
  146. Pope HG Jr, Kanayama G. Abuse of anabolic androgenic steroids in society: a problem underrecognized by the medical profession. First Nordic Conference on Abuse of Anabolic Steroids and Anti-Doping Work. Stockholm, Sweden, September 20, 2007.
  147. Pope HG Jr. Illicit anabolic steroid use in the United States: a psychiatric perspective. California Society of Addiction Medicine (CSAM), Los Angeles, CA, October 19, 2007.
  148. Pope HG Jr. Affective spectrum disorder. XV International Symposium about current issues and controversies in psychiatry: Beyond the Kraepelinian nosology . Barcelona, Spain April 3-4, 2008.
  149. Pope CG, Pope HG, Menard W, Phillips KA. Substance abuse and dependence in subjects with body dysmorphic disorder in a longitudinal study. 12th Annual Research Symposium on Mental Health Sciences. Providence, RI: The Warren Alpert Medical School of Brown University, 2008;65

Books:

  1. Pope HG Jr. Voices from the drug culture. Boston: Beacon Press, 1971.
  2. Pope HG Jr. The road east. Boston: Beacon Press, 1974.
  3. Pope HG Jr, Hudson JI. New hope for binge eaters: advances in the understanding and treatment of bulimia. New York: Harper and Row, 1984.
  4. Hudson JI, Pope HG Jr. Eds. The psychobiology of bulimia. Washington D.C.: American Psychiatric Press, 1987.
  5. McElroy SL, Pope HG Jr. Eds. Use of anticonvulsants in psychiatry: recent advances. Clifton, N.J.: Oxford Health Care, l988.
  6. Pope HG Jr. Psychology astray: fallacies in studies of “repressed memory” and childhood trauma. Boca Raton, FL: SIRS, 1997.
  7. Pope HG Jr, Phillips KA, Olivardia R. The Adonis complex: the secret crisis of male body obsession. New York, NY: Free Press, 2000.
    (Portuguese edition): Pope HG, Jr, Phillips KA, Olivardia R. O complexo de Adonis. A obsessao masculina pelo corpo. Trans.Teixeira SA. Rio de Janeiro: Editora Campus Ltda., 2000.
    (German edition): Pope HG Jr, Phillips KA, Olivardia R. Das Adoniskomplex. Munich: Deutschen Taschenbuch Verlag, 2000.
    (Greek edition): Pope HG Jr, Phillips KA, Olivardia R. [The Adonis complex: the secret crisis of male body obsession]. Athens: Editions Thymari, 2001
    (Chinese edition): Pope HG Jr, Phillips KA, Olivardia R. [The Adonis complex: the secret crisis of male body obsession]. Taipei: Cite, 2002.
    (Latin American edition): Pope HG Jr, Phillips KA,Olivardia R [The Adonis Complex: the secret crisis of male body obsession]. Oceano, 2002.
    (Chinese edition): Pope HG Jr, Phillips KA, Olivardia R. [The Adonis complex: the secret crisis of male body obsession]. Chongqing, Chongqing Publishing House, 2005.

Reviews and Educationally Relevant Publications:

  1. Pope HG Jr. Differential diagnosis of acute psychotic disorders. In: Flach FF, ed. Directions in psychiatry, lesson 7. New York, 1981.
  2. Pope HG Jr. “Three voices” and “Radar messages.” In: Spitzer RL, Skodol AE, Gibbon M, Williams JBW, eds. DSM-III case book. Washington DC: American Psychiatric Press, 1981.
  3. Pope HG Jr. Schizophrenia. In: Encyclopaedia Britanica medical and health annual. Chicago, 1983:72-83.
  4. Hudson JI, Pope HG Jr, and Jonas JM: Treatment of bulimia with antidepressants. Psychiatric Annals 1983;13:965-9.
  5. Hudson JI, Pope HG Jr, Jonas JM. Treatment of bulimia with antidepressants: theoretical considerations and clinical findings. In: Stunkard AJ, Stellar E ed. Eating and its disorders. New York: Raven Press, 1984, 259-73.
  6. Jonas, JM, Pope HG Jr. The approach to specific factitious symptoms and signs. In: Hyman S, ed. A Manual of Psychiatric Emergencies. Boston: Little Brown and Co., 1984; pp 207-13.
  7. Pope HG Jr, Hudson JI. Biological treatment of eating disorders. In: Emmett SW, ed. Theory and treatment of eating disorders: biomedical, sociocultural, and psychological perspectives. New York, Brunner/Mazel, 1985, pp 73-92.
  8. Hudson, JI, Pope HG Jr. The use of antidepressants in bulimia. Int Med for the Specialist 1985;6:142-54.
  9. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Antidepressant treatment of bulimia: a research update. In: Kaye W, Gwirtsman H, eds. Physiology and treatment of bulimia in normal weight women. Washington: American Psychiatric Press, 1985, pp 119-31.
  10. Pope HG Jr. Psychopharmacology. In: Kuper A, Kuper J, eds. The social science encyclopaedia. London: Routledge and Kegan Paul, 1985, pp 670-1.
  11. Jonas JM, Pope HG Jr, Hudson JI, Cohen BM, Tohen M. Psychosis in borderline personality disorder. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D. eds. Biological Psychiatry 1985. New York: Elsevier Science Publishing Co., 1986, pp 571-93.
  12. Pope HG Jr, Hudson JI. Bulimia in men. Human Sexuality 1986;20:33-7.
  13. Pope HG Jr, Hudson JI, Jonas JM. Treatment of bulimia with thymoleptic medications: theoretical considerations and clinical findings. In: LaRocca FEF, ed. Eating disorders: effective care and treatment. St. Louis: Ishiyaku Euro-America, 1986;151-72.
  14. Pope HG Jr. What we know about bulimia nervosa in 1986. Currents in Affective Illness 1986, V:7:5-12, 1986.
  15. Hudson JI, Pope HG Jr. Treatment of bulimia: review of current studies. In: LaRocca FEF, ed. Eating Disorders. San Francisco, Jossey-Bass, 1986, pp 71-85.
  16. Pope HG Jr, Keck PE Jr. The neuroleptic malignant syndrome: what is it and how is it treated? Harvard Medical School Health Letter, October, 1987, p 8.
  17. Hudson JI, Pope HG Jr. Eating disorders and depression. In: Cameron OG, ed. Presentations of depression: depressive symptoms in medical and other psychiatric disorders. New York, John Wiley, 1987, pp 33-66.
  18. Fulwiler CE, Pope HG Jr. Personality disorders and depression. In Cameron OG, ed. Presentations of depression: depressive symptoms in medical and other psychiatric disorders. New York, John Wiley, 1987, pp. 107-30.
  19. Hudson JI, Pope HG Jr, Jonas JM, Kupfer DJ. Sleep EEG in bulimia. In: Hudson JI, Pope HG Jr, eds. The psychobiology of bulimia. Washington D.C.: American Psychiatric Press, 1987, pp. 185-202.
  20. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun- Todd D: Antidepressant treatment of bulimia: A two-year follow-up study. In Hollister LE, Lasagna L, eds. The year book of drug therapy annual. Chicago: Year Book Medical Publishers, 1987, p. 420.
  21. Pope HG Jr, Hudson JI. The treatment of bulimia nervosa with antidepres-sants. In: Abraham S, Llewellyn-Jones D, eds. Eating disorders and disordered eating. Sydney: Ashwood House, l987, pp. 117-21.
  22. Pope HG Jr. Psychiatric side effects of anabolic steroids. Currents in Affective Illness VII:7:5-11, 1988.
  23. Pope HG Jr. Bulimia. In: The World Book Encyclopaedia. Chicago: World Book Encyclopaedia, l988 edition, vol. II, p. 704.
  24. Pope HG Jr. Differential diagnosis of acute psychotic disorders. In: Flach F, ed. Diagnostics and psychopathology. New York, Hatherleigh Co., l988, pp. 39-48.
  25. Katz DL, Pope HG Jr. Psychiatric effects of anabolic steroids. In: Garrett WE, Malone TR, eds. Muscle development: nutritional alternatives to anabolic steroids. Columbus, OH: Ross Laboratories, 1988, pp. 41-4.
  26. Hudson JI, Pope HG Jr. The role of anticonvulsants in the treatment of bulimia. In: McElroy SM, Pope HG Jr. Use of anticonvulsants in psychiatry: recent advances. Clifton, NJ: Oxford Health Care, l988, pp. 141-54.
  27. McElroy SM, Keck PE Jr, Pope HG Jr, Hudson JI. Valproate in primary psychiatric disorders: literature review and clinical experience in a private psychiatric hospital. In McElroy SM, Pope HG Jr, eds. Use of anticonvulsants in psychiatry: recent advances. Clifton, NJ: Oxford Health Care, l988, pp. 25-41.
  28. Pope HG Jr, Hudson JI, Spitzer RL, Williams JBW. Revisions to the DSM-III criteria for bulimia nervosa. In: Garner DM, Garfinkel PE, eds. Diagnostic issues in anorexia nervosa and bulimia nervosa. New York: Brunner-Mazel. l988, pp. 26-35.
  29. McElroy SL, Keck PE Jr, Pope HG Jr. Valproate in primary psychiatric disorders. Mind 1988; 2:11-4.
  30. Hudson JI, Pope HG Jr. Citation classic: Studies of the relationship between bulimia and major affective disorder. Commentary on Br J Psychiatry. l42:l33-8, l983 and Am J Psychiatry. l40:554-8, l983. Current Contents (Social and Behavioral Sciences) l988;5:18.
  31. Pope HG Jr, Lipinski JF. Citation Classic: Diagnosis in schizophrenia and manic depressive illness. Commentary on Arch Gen Psychiatry l978;35:8ll-828. Current Contents (Social and Behavioral Sciences) l988;24:24.
  32. Pope HG Jr, Hudson JI. Eating disorders. In: Tupin JP, Shader RI, Harnett DS, eds. Handbook of clinical psychopharmacology. New York: Jason Aronson, 1988, pp. 245-67.
  33. Pope HG Jr, Hudson JI. Bulimia nervosa. In: Rakel RE, ed. 1989 Conn’s current therapy. Philadelphia: WB Saunders, 1989, pp. 989-94.
  34. Pope HG Jr, Hudson JI. Eating disorders. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry/V. Baltimore: Williams & Wilkins, 1989, pp. 1854-64.
  35. Hudson JI, Pope HG Jr. Psychopharmakologische Behandlung der Bulimia. In: Fichter MM, ed. Bulimia Nervosa: Grundlagen und Behandlung. Stuttgart: Enke Verlag, 1989, pp.284-292. Appears in English language edition as: Psychopharmacologic treatment of bulimia. In: Fichter MM, ed. Bulimia nervosa: basic research, diagnosis and therapy. New York: John Wiley & Sons, 1990, pp. 331-42.
  36. Pope HG Jr, Katz DL. Psychiatric effects of doping with anabolic-androgenic steroids. In: Bellotti P, Benzi G, Ljungqvist A, eds. IInd I.A.F. World Symposium on Doping in Sport. London: International Athletic Foundation, 1989, pp. 117-22.
  37. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry 1989; 50(3, suppl):23-9.
  38. Pope HG Jr, Hudson JI. Pharmacologic treatment of bulimia nervosa: research findings and practical suggestions. Psychiatric Annals 1989;19:483-7.
  39. Ionescu-Pioggia M, Varma D, Pope HG Jr, Cole, J. College undergraduate drug use and lifestyle: a comparison - 1969, 1978, and 1989. National Institute on Drug Abuse Research Monograph Series 105:285-6, 1990.
  40. Katz DL, Pope HG Jr. Anabolic-androgenic steroid-induced mental status changes. National Institute of Drug Abuse Research Monograph Series: Anabolic Steroid Abuse. Rockville, MD: National Institute of Drug Abuse, 1990, pp. 215-23.
  41. Lipinski JF Jr, Mallya G, Zimmerman P, Pope HG Jr. Fluoxetine and akathisia. J Clin Psychiatry 1990; 51:211-2.
  42. Pope HG Jr. Anabolic-andogenic steroid use and suicide. Physician Sportsmed. 1990;18:16.
  43. Pope HG Jr, Katz DL. What are the psychiatric effects of anabolic steroids? Harvard Mental Health Letter, April 1991, p 8.
  44. Pope HG Jr. Valproic acid for the treatment of mania. Currents in Affective Illness 1991, X:4:5-13.
  45. Pope HG Jr, Katz DL. Homicido y casi-homicido en usuarios de esteroides anabolicos. Psychiatry Digest 1991;1:7-8.
  46. Keck PE Jr, McElroy SL, Pope HG Jr. Epidemiology of neuroleptic malignant syndrome. Psychiatric Annals 1991; 21:148-51.
  47. Keck PE Jr, McElroy SL, Pope HG Jr. Neuroleptic malignant syndrome. Current Opinion in Psychiatry 1991; 4:34-7.
  48. Hudson JI, Pope HG Jr. Affective spectrum disorder? Am J Psychiatry 1991; 148:548-9.
  49. Pope HG Jr, Katz DL. Psychiatric effects of anabolic steroids. Psychiatric Annals 1992;22:24-9.
  50. Jonas JM, Pope HG Jr. Axis I comorbidity of borderline personality disorder. In Clarkin JF, Marziali E, Munroe-Blum H, eds. Borderline personality disorder, Vol. 1. New York: Guilford Press, 1992, pp. 149-60.
  51. Pope HG Jr, Aizley HG, Keck PE Jr, McElroy SL. Neuroleptic malignant syndrome: long-term follow-up of 20 cases. Psychiatry Digest 1992; 1:24-5.
  52. Pope HG Jr, Choi PYL. Psychiatric effects of anabolic steroids. Psychiatric Times. 1992; IX:18-21.
  53. Hudson JI, Pope HG Jr. Affective spectrum disorder. Depression Briefings 1992;3:34-6.
  54. Hudson JI, Pope HG Jr. Update on the use of fluoxetine in the treatment of bulimia nervosa. American Anorexia/Bulimia Association Newsletter, Special Research Edition. Fall 1992, pp. 1-2.
  55. Pope HG Jr., Hudson JI. Childhood sexual abuse and bulimia nervosa: is there an association? American Anorexia/Bulimia Association Newsletter, Special Research Edition. Fall 1992, p. 6.
  56. McElroy SL, Keck PE, Jr, Pope HG, Jr, Hudson JI. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol 1992 (suppl);12:42-52.
  57. Strauss RH, Catlin DH, Liggett MT, Pope HG Jr, Wright J. Roundtable discussion on the effects of anabolic steroids. The Physician and Sportsmed 1993; 21:37-44.
  58. Pope HG Jr, Hudson JI. Is childhood sexual abuse a risk factor for bulimia nervosa? Am J Psychiatry 1993; 150:357-8.
  59. Pope HG Jr. A practical approach to affective spectrum disorder. Upjohn Masters in Psychiatry Series, October 1993. pp. 8-13.
  60. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC. Dysphoric mania. Am J Psychiatry 1993; 150:1908-9.
  61. Kouri E, Pope HG Jr, Katz D. Use of anabolic-androgenic steroids: we are talking prevalence rates. JAMA 1994; 271:347.
  62. Pope HG Jr. Update on the treatment of bipolar depression. Currents in Affective Illness 1994, XIII:5:5-13.
  63. Pope HG Jr. “Three voices” and “Radar messages.” In: Spitzer RL, Gibbon M, Skodol AE, Williams JBW, First MB. eds. DSM-IV case book. Washington DC: American Psychiatric Press, 1994.
  64. Pope HG Jr. “Recovered memories”: recent events and review of evidence. Currents in Affective Illness. 13:5-12, 1994.
  65. Pope HG Jr, McElroy SL. Valproic acid. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry/VI. Baltimore: Williams & Wilkins, 1995, pp. 2112-20.
  66. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI. Disorders of impulse control. In: Hollander E and Stein D, eds. Impulsive aggression and disorders of impulse control. Chichester, UK: John Wiley & Sons, 1995, pp.109-36.
  67. Pope HG Jr, Mick TM. Les effets psychiatriques des steroides anabolisants. Medecine et Hygiene 1995;53:1570-1574.
  68. Kulick AR, Pope HG Jr, Keck PE Jr. Lycanthropy and self-identification. In Swezey S, ed. Amok Journal: Sensurround edition - A compendium of psychophysiological investigations. Los Angeles, CA: Amok books, 1995, pp. 454-9.
  69. Pope HG Jr, Hudson JI. Can individuals “repress” memories of childhood sexual abuse? An examination of the evidence. Psychiatric Annals 1995;25:715-9.
  70. Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use: a controlled study of 160 athletes. In: Lasagna L, ed. 1995 Yearbook of Drug Therapy. Chicago: Mosby-Year Book, 1995, pp. 28-9.
  71. Kouri EM, Pope HG Jr. Psychiatric and medical effects of steroid use. Directions in Psychiatry March 31, 1996; 16:Lesson 7:1-12.
  72. Pope HG Jr, Hudson JI. Anorexia nervosa and “reverse anorexia.” National Eating Disorders Organization Newsletter. Spring, 1996;30:1-2.
  73. Olivardia R, Pope HG Jr. Eating disorders in college men. Clinician’s Research Digest, May 1996;14:3.
  74. Gruber AJ, Pope HG Jr. Cannabis-related disorders. In: Tasman A, Kay J, Lieberman JA (eds.) Psychiatry. Philadelphia: WB Saunders, 1996, pp 795-806.
  75. Olivardia R, Pope HG Jr. Eating disorders in men: prevalence, recognition, and treatment. Directions in Psychiatry 1997; XVII: 41-51
  76. Pope HG Jr, Kouri EM, Powell KF, et al. Anabolic androgenic steroid use among 133 prisoners. In: Talbott JA. (ed). The Year Book of Psychiatry and Applied Mental Health. St. Louis, MO: Mosby, 1998, pp 167-8.
  77. Gruber, AJ, Pope HG Jr. Anthropometry, steroids & body image. Kinanthreport XI:1 January 1998, pp 4-6.
  78. Pope HG Jr. Recovered memories of childhood sexual abuse: The Royal College of Psychiatrists issues important precautions. Br Med J. 1998;316:488-9.
  79. Gruber AJ, Pope HG Jr. Muscle dysmorphia. OCD Newsletter. Volume 12, April, 1998. pp. 1, 7.
  80. Pope HG Jr, Oliva PS, Hudson JI. The scientific status of repressed memories. In Faigman DL, Kaye DH, Saks MJ, Sanders J, eds. Modern scientific evidence: the law and science of expert testimony. Vol 1, 1999 Pocket part. St. Paul, MN: West Publishing Co., 1999, pp. 115-155; 2000 pp. 154-95, Vol 1, Pocket part. St. Paul, MN: West Publishing Co.
  81. Pope HG Jr. The long-term effects of childhood trauma: how much do we really know? Pain Research & Management Spring 1999;4: 13-4.
  82. Hudson JI, Pope HG Jr, Carter WP. Pharmacologic therapy of bulimia nervosa. In Goldstein D, ed. The management of eating disorders and obesity. Totowa, New Jersey: Humana Press, Inc. 1999, pp. 19-32.
  83. McElroy SL, Pope HG Jr, Keck PE Jr. Valproate In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry/VII. Baltimore: Lippincott Williams & Wilkins, 2000, pp 2289-99.
  84. Pope HG Jr, Brower KJ. Anabolic-Androgenic Steroid Abuse. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry/VII. Philadelphia PA: Lippincott Williams & Wilkins, 2000, 1085-95.
  85. Pope HG Jr, Kanayama G. Abuse of anabolic-androgenic steroids. Pharmaceutical News 2000;7:13-20.
  86. Palmer C.M. and Pope H.G. Jr. 2000. Antiepileptic Drugs. In M.G. Gelder, J.J.Lopez- Ibor Jr., and N. Andreason (Eds.), The New Oxford Textbook of Psychiatry. New York: Oxford University Press, 2000. pp. 1326-1333.
  87. Pope HG Jr. “The Adonis Complex.” Psychiatric Times 2001;XVIII:53-6.
  88. Gruber, AJ, Pope HG Jr. Marijuana. In Craighead WE and Nemeroff CB eds. The Corsini Encyclopedia of Psychology and Behavioral Science, Third Edition. New York, NY: John Wiley & Sons, 2001, pp 917-8.
  89. Kanayama G, Pope HG Jr, Hudson JI. “Body image”drugs: a growing psychosomatic problem. Psychother Psychosom 2001;70:61-5.
  90. Pope HG Jr., Gruber AJ, Yurgelun-Todd D. Residual neuropsychological effects of cannabis. Current Psychiatry Reports 2001;3:507-12.
  91. Pope HG Jr, Kanayama G. Anabolic-Androgenic steroids. Society for the Psychological Study of Men and Masculinity Bulletin 2001;6:9-11.
  92. Olivardia R, Pope HG Jr. Body image disturbance in childhood and adolescence. In Castle D, Phillips K, eds Disorders of Body Image, Petersfield, UK: Wrightson Biomedical Publishing, 2002. Pp 83-100.
  93. Pope HG Jr. Cannabis, cognition and residual confounding. JAMA 2002;287:1172-4.
  94. Pope HG Jr. Cognitive Performance in long-term marijuana users. Journal Watch Neurology 2002 May; 5:36-7.
  95. Gruber AJ, Pope HG Jr. Marijuana use among adolescents. Pediatr Clin North Am 2002;49:389-413.
  96. Pope HG Jr. Delayed disclosure by victims of child sexual abuse: an important topic for study. Acta Pediatrica 2002;91:1293-5.
  97. Pope HG Jr, Oliva PS, Hudson JI. Repressed memories. The scientific status of research on repressed memories. In: Faigman DL, Kaye DH, Saks MJ, Sanders J, eds. Science in the law: social and behavioral science issues. St. Paul, MN: West Group, 2002, pp 487-526.
  98. Pope HG Jr., Katz DL. Psychiatric effects of exogenous anabolic-androgenic steroids. In: Wolkowitz OM, Rothschild AJ (eds.) Psychoneuroendocrinology: The Scientific Basis of Clinical Practice. Washington. D.C.: American Psychiatric Press, 2003. Pp 331-58.
  99. Carter WP, Pope HG Jr. Steroid abuse: a “hidden” health hazard. Current Psychiatry 2003;2:65-71.
  100. Gruber AJ, Pope HG Jr. Cannabis-related disorders. In: Tasman A, Lieberman JA, Kay J, (eds.) Psychiatry. United Kingdom: Wiley and Sons, 2003. Pp 995-1009.
  101. Pope HG Jr, Hudson JI. Bulimia nervosa: persistent disorder requires equally persistent treatment. Current Psychiatry 2004;3:13-22.
  102. Pope HG Jr, Brower KJ. Anabolic-androgenic steroids. In: Galanter M and Kleber HD, ed. American Psychiatric Publishing Textbook of Substance Abuse Treatment, 3rd ed. Washington DC: American Psychiatric Publishing, 2004. Pp 257-64.
  103. Pope HG Jr, Yurgelun-Todd, D. Residual cognitive effects of long-term cannabis use. In: Castle DJ, Murray RM ed. Marijuana and Madness Cambridge, UK: Cambridge University Press, 2004. Pp 198-210.
  104. Pope HG Jr, Kanayama G. Bodybuilding’s dark side: clues to anabolic steroid use. Current Psychiatry 2004;3:12-20.
  105. Pope HG Jr, Brower KJ. Anabolic-Androgenic Steroid Abuse. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry/VIII. Philadelphia PA: Lippincott Williams & Wilkins, 2005. Pp1318-28.
  106. Hudson JI, Pope HG Jr, Carter WP. Pharmacologic therapy of bulimia nervosa. In: Goldstein D, ed. The management of eating disorders and obesity, 2nd ed. Totowa, New Jersey: Humana Press, Inc., 2005. Pp 23-39.
  107. Hudson JI, Hudson RA, Pope HG Jr. Psychiatric comorbidity and eating disorders. In: Wonderlich S, Mitchell JE, de Zwaan M, Steiger H, eds. Eating disorders review: part I. Oxford: Radcliffe Publishing, 2005, pp 43-57.
  108. Pope HG Jr, Kanayama G. Can you tell if your patient is using anabolic steroids? Current Psychiatry in Primary Care, 2005: 1 No. 2: 28-34.
  109. Pope H, Oliva P, Hudson J: Repressed memories. The scientific status of research on repressed memories, in Modern Scientific Evidence: The Law and Science of Expert Testimony — Social and Behavioral Science, 2005-2006 Edition. Edited by Faigman D, Kaye D, Saks M, Sanders J. Eagen, MN, West Group, 2005, pp 408-447
  110. Pope HG Jr, Kanayama G. Steroids. Entry for the International Encyclopedia of Social Sciences, 2nd Edition, 2005, in press.
  111. Pope HG Jr, Brower KJ. Treatment of anabolic-androgenic steroid abuse. In: Galanter M and Kleber HD, ed. American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th ed. Washington DC: American Psychiatric Publishing, in press.
  112. Brennan BP, Pope HG Jr. Antiepileptic Drugs. In M.G. Gelder, J.J.Lopez- Ibor Jr., and N. Andreason (Eds.), The New Oxford Textbook of Psychiatry. New York: Oxford University Press, in press.

Letters

  1. Pope HG Jr. Drug abuse and psychopathology. N Engl J Med 1980; 302:870.
  2. Hudson JI, Laffer PS, Pope HG Jr. Bulimia and the dexamethasone suppression test. Am J Psychiatry 1982;139:1524.
  3. Pope HG Jr, Jonas JM, Cohen BM, Lipinski JF. Heritability in schizophrenia. Am J Psychiatry 1983;140:131.
  4. Pope HG Jr, Hudson JI, Yurgelun-Todd D. “Shopping center” epidemiology. Am J Psychiatry 1984;141:1138.
  5. Jonas JM, Pope HG Jr., Hudson JI, Satlin A. Are DSM-III criteria for bulimia too broad? Am J Psychiatry 1985;142:393.
  6. Baldessarini RJ, Pope HG Jr, Cohen BM, Lipinski JF. The neuroleptic malignant syndrome. N Engl J Med 1985;313:1293.
  7. Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG Jr. Psychiatric disorders in fibromyalgia. Am J Psychiatry 1986;143:813.
  8. Keck PE Jr, Pope HG Jr, McElroy SL. Haloperidol in neuroleptic malignant syndrome. Am J Psychiatry 1988;45:654.
  9. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Valproate in rapid-cycling bipolar disorder. J Clin Psychopharmacol 1989;9:383-4.
  10. Phillips KA, Pope HG Jr, McElroy SL, Hudson JI, Keck PE Jr. Body dysmorphic disorder: symptom or syndrome. Am J Psychiatry 1994;151:461-2.
  11. Pope HG Jr, Yurgelun-Todd D. Cognitive effects of marijuana. JAMA 1996;275:1547.
  12. Mayer P, Pope HG Jr. Unusual flashbacks in a Vietnam veteran. Am J Psychiatry 1997;154:713.
  13. Hochman J, Pope HG Jr. Debating dissociative diagnoses Am J Psychiatry 1997;153:887-8.
  14. Phillips KA, O’Sullivan RL, Pope HG Jr. Muscle dysmorphia. J Clin Psychiatry 1997;58:361.
  15. Pope HG Jr. Is psychoanalysis science? N Engl J Med 1997;337:1635.
  16. McElroy SL, Pope HG Jr. Response to ‘The Civil Commitment of Sex Offenders. Science 1998;279:10.
  17. Pope HG Jr. Recovered memories of childhood abuse. Br Med J 1998;317:1012.
  18. Arvary D, Pope HG Jr. Anabolic steroids: a possible gateway to opioid dependence. N Engl J Med 2000;342:1532.
  19. Pope HG Jr, Oliva PS, Hudson JI, Bodkin JA, Gruber AJ. Psychiatrists’ attitudes towards dissociative disorders diagnoses. Am J Psychiatry 2000;157:1181-2.
  20. Lalonde JK, Hudson JI, Pope HG Jr. RE: Canadian and American psychiatrists’ attitudes toward dissociative disorder diagnosis. The authors reply. Can J Psychiatry 2002;47:282-83.
  21. Pope HG Jr. Response to “Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment.” JAMA 2002;287:2654.
  22. Halpern JH, Pope HG JR, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd DA. Reply to Lyvers and Hasking (2004) Drug Alcohol Depend 2004;75:153.
  23. Pope HG Jr. The nature of traumatic memories. Response to Lanius et al. Am J Psychiatry 2004;161:1927.
  24. Kihlstrom JF, McNally RJ, Loftus EF, Pope HG Jr. The problem of child sexual abuse. Science 2005;309:1182-3.
  25. Pope HG Jr, Barry S, Bodkin JA, Hudson JI. The validity of the dissociative disorders–Reply to Veldhuizen. Psychother Psychosom 2007;76:59-60.
  26. Pope HG Jr, Barry S, Bodkin JA, Hudson JI. Reply to Dahlenberg et al. Scientific study of the dissociative disorders Psychother Psychosom. 2007;76:401-403.
  27. Pope HG Jr, Poliakaoff MB, Parker MP, Boynes M, Hudson JI. Is dissociative amnesia a cultural artifact?–Reply to Spiegel. Psychol Medicine 2007;1065-1067.
  28. Pope HG Jr, Poliakaoff MB, Parker MP, Boynes M, Hudson JI. Is dissociative amnesia a cultural artifact?–Reply to Altshuler, Ramachandran, and Ravi. Psychol Medicine 2007;1067-1068.
  29. McElroy SL, Guerdjikova AI, Martens B, Keck PE Jr., Pope HG, Hudson JI. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs, In press.

Academic & Medical Web Design by Thomboy Productions